supp.fit

Vitamin E: study protocols

906 study groups say how much Vitamin E participants took a day. These are the doses the studies gave. They are not a recommendation.

Vitamin E: what the research found →

Dose per serving from products

15,157 products in our catalogue print how much Vitamin E a serving holds.

Most common: 10 mg to 25 mg, 44% of 15,157 products.

Dose per servingProducts
1 mg or less
580
1 mg to 2.5 mg
297
2.5 mg to 5 mg
1,208
5 mg to 10 mg
2,624
10 mg to 25 mg
6,652
25 mg to 50 mg
1,374
50 mg to 100 mg
989
100 mg to 250 mg
783
over 250 mg
650

Dose per serving from research

533 study groups in 370 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 24% of 533 study groups.

Daily doseStudy groups
5 mg or less
18
5 mg to 10 mg
13
10 mg to 25 mg
31
25 mg to 50 mg
90
50 mg to 100 mg
52
100 mg to 250 mg
94
250 mg to 500 mg
130
500 mg to 1 g
83
over 1 g
22

Commonly used together

443 of 906 study groups took Vitamin E with something else. Shown: what 3 or more different studies gave. The 10 most common of 29.

What was given together, not what works together.

Taken withStudy groups
Vitamin C
269
Beta-Carotene
114
Zinc
57
Selenium
56
Omega-3 Fatty Acids
37
Vitamin A
29
Folic Acid
22
Copper
16
Iron
16
Vitamin B12
16

906 study groups

Study
[Luobufukebiri Pills improve semen quality and seminal plasma-related biochemical indexes in patients with asthenospermia]
2020 · control group · Patients with asthenospermia; age and sex details not reported
200 mg12 weeks103
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico
1999 · Vitamin E · Patients who survived a recent myocardial infarction (within 3 months); age and sex not specified
300 mg1278 days2,830
Does palm oil vitamin E reduce the risk of pregnancy induced hypertension?
2013 · TRF arm · Healthy primigravidae, from early second trimester until delivery
100 mg—151
Effects on health of dietary supplementation with 100 mg d-alpha-tocopheryl acetate, daily for 6 years
1995 · 100 mg group · Healthy volunteers aged 39 to 56 years
100 mg6 years74
Effects of Low-Dose Aspirin Combined with Vitamin E on the Incidence of Intrauterine Growth Restriction and Hemorheological Indexes of Pregnant Women in Patients with Gestational Hypertension
2022 · control group · Pregnant women aged 21–35 with gestational hypertension
150 mg—67
Effects of Low-Dose Aspirin Combined with Vitamin E on the Incidence of Intrauterine Growth Restriction and Hemorheological Indexes of Pregnant Women in Patients with Gestational Hypertension
2022 · observation group · Pregnant women aged 20–37 with gestational hypertension
150 mg—67
Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks
1995 · aspirin plus vitamin E · Patients with transient ischemic attacks, minor strokes, or residual ischemic neurologic deficits
400 mg2 years52
Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial
2010 · Combination clomiphene citrate and vitamin E group · Infertile men with idiopathic oligoasthenozoospermia
400 mg26 weeks30
Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy
2003 · group one · Patients with cancer receiving cisplatin chemotherapy
300 mg——
[Gujing Maisiha Tablets combined with natural vitamin E for the treatment of idiopathic asthenospermia]
2017 · control group · Men aged 21–43 with idiopathic asthenospermia
200 mg90 days55
Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial
2012 · Metformin group · People with non-alcoholic fatty liver disease; age and sex not specified
200 mg90 days43
Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial
2017 · group B · Patients with differentiated thyroid cancer undergoing postsurgical radioiodine ablation
200 mg5 weeks22
Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies
2000 · vitamin E · Norplant users with endometrial bleeding and at least 3 months of Norplant exposure; age and sex not further stated
200 mg60 days—
Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis
2000 · vitamin E · Smoking and nonsmoking men and postmenopausal women aged 45–69 years with serum cholesterol ≥5.0 mmol/L
182 mg3 years—
Arterial compliance and vitamin E blood levels with a self emulsifying preparation of tocotrienol rich vitamin E
2008 · 200 mg SF-TRE group · healthy adult males
200 mg60 days—
Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study
2009 · Vitamin E group · Women aged 65 years or older in the cognitive substudy, with cardiovascular disease or at least three coronary risk factors
201 mg3249 days—
Tocotrienol-Enriched Beverage Enhances Psychological Well-Being, Antioxidant Defense, and Genomic Stability in Older Adults: A Randomized Controlled Trial
2025 · Group A (intervention group) · Adults aged 50–70 years in generally good health
200 mg26 weeks—
Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial
1997 · 200 mg/d vitamin E group · Healthy free-living adults aged 65 years or older
200 mg235 days—
The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
2020 · α-Tocopherol alone (AT) · Male smokers aged 50–69 years who smoked at least 5 cigarettes per day at entry
50 mg2227 days14,564
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
1996 · alpha-tocopherol 800 IU daily · Patients with angiographically proven coronary atherosclerosis; age and sex not stated
800 IU510 days546
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
1996 · alpha-tocopherol 400 IU daily · Patients with angiographically proven coronary atherosclerosis; age and sex not stated
400 IU510 days489
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
2000 · vitamin E · Haemodialysis patients aged 40–75 years with pre-existing cardiovascular disease
800 IU519 days97
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
2010 · vitamin E group · Adults without diabetes with biopsy-confirmed nonalcoholic steatohepatitis
800 IU96 weeks84
Effects on health of dietary supplementation with 100 mg d-alpha-tocopheryl acetate, daily for 6 years
1995 · 3 mg group · Healthy volunteers aged 39 to 56 years
3 mg6 years73
Selenium and Vitamin E for Prevention of Non-Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial
2023 · vitamin E and selenium placebo · Adults aged 18 years or older with newly diagnosed, pathologically confirmed non-muscle-invasive bladder cancer
200 IU548 days71
Efficacy of water-based vitamin E solution versus placebo in the prevention of retinopathy of prematurity in very low birth weight infants: A randomized clinical trial
2021 · Group T (treatment group) · Very low birth weight infants with respiratory distress syndrome
25 IU25 days48
Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial
2013 · tocotrienols group · Adults aged 36–74 with ultrasound-proven NAFLD and mild untreated hypercholesterolaemia
522 mg1 year43
[Efficacy and safety of vitamin D in the treatment of idiopathic oligoasthenozoospermia]
2014 · control group · Men with idiopathic oligoasthenozoospermia
300 mg90 days43
Delta tocotrienol as a supplement to FOLFOXIRI in first-line treatment of metastatic colorectal cancer. A randomized, double-blind, placebo-controlled phase II study
2023 · δ-tocotrienol group · Adults aged 18–75 with metastatic colorectal adenocarcinoma receiving first-line FOLFOXIRI chemotherapy
900 mg2 years35
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial
2005 · Group I · Patients with cancer treated with cisplatin, paclitaxel, or their combination regimens
600 mg—16
Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation
2006 · Group I · Patients with cancer undergoing paclitaxel-based chemotherapy
600 mg—16
A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results
2006 · group I · Patients with cancer scheduled to receive cisplatin-based chemotherapy; age and sex not reported
600 mg—14
The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers
1999 · alpha-tocopherol (AT) · middle-aged male smokers
50 mg——
Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers
2000 · alpha-tocopherol · Men aged 50 to 69 who smoked cigarettes and had no history of stroke
50 mg6 years—
Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
2000 · alpha tocopherol · Men aged 50–69 who smoked and were included in the high-risk-for-stroke subgroup analysis; subgroup condition included hypertension
50 mg6 years—
Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study
2004 · alpha-tocopherol · men aged 50–69 who smoked
50 mg8 years—
Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA)
1992 · vitamin E group · Patients after successful percutaneous transluminal coronary angioplasty (PTCA)
1,200 IU122 days—
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial
2005 · vitamin E group · Apparently healthy US women aged at least 45 years
300 IU368 days—
[A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia]
2005 · control group · men with oligoasthenozoospermia
300 mg90 days—
Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial
2007 · alpha-tocopherol only · Male smokers aged 50–69 years, free of cancer at baseline
50 mg2227 days—
A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study
2007 · Vitamin E group · Women aged 40 years or older with a history of cardiovascular disease or at least three cardiovascular risk factors
300 IU3431 days—
Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study
2007 · vitamin E group · Women aged 45 years or older; healthy women, including women with and without prior VTE
300 IU372 days—
Deprenyl's effect at slowing progression of parkinsonian disability: the DATATOP study. The Parkinson Study Group
1991 · alpha-tocopherol group · People with mild Parkinsonism
2,000 IU1 year—
Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake
2008 · Vitamin E · Males aged 50–69 years who smoked at baseline and had no tuberculosis diagnosis before randomisation
50 mg2228 days—
Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk
2009 · vitamin E group · Men aged 50–69 years in southwestern Finland who smoked at least five cigarettes per day
50 mg2228 days—
Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C
2009 · vitamin E · men aged 50–69 years who smoked at least 5 cigarettes per day
50 mg8 years—
Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival
2009 · α-tocopherol · Caucasian male smokers aged 50–69 years; prostate cancer cases were analysed in this report
50 mg8 years—
Randomised vitamin E supplementation and risk of chronic lung disease in the Women's Health Study
2011 · Vitamin E group · Female healthcare professionals aged 45 years or older, without major chronic illness at enrolment
300 IU10 years—
Effect of intramuscular vitamin E on mortality and intracranial hemorrhage in neonates of 1000 grams or less
1990 · Control group · Premature neonates weighing 501–1000 g and aged 24 hours or less
100 mg/kg6 days—
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
2011 · vitamin E group · Healthy men at average risk of prostate cancer; age 50 or older for African Americans and 55 or older for others
400 IU2008 days—
Reduced mortality among children in southern India receiving a small weekly dose of vitamin A
1990 · control group · Preschool-age children in southern India
2.86 mg1 year—
Vitamin E supplementation and the risk of heart failure in women
2012 · vitamin E · Women aged 45 years or older, apparently healthy and free of cardiovascular disease and cancer
300 IU373 days—
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT
2012 · vitamin E · Men aged 50 years or older if Black and 55 years or older otherwise, without prior prostate cancer diagnosis
400 IU6 years—
Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis
2013 · α-tocopherol alone · Finnish male smokers aged 50–69
50 mg2227 days—
Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
2014 · vitamin E · African-American men aged 50 years or older and non-African-American men aged 55 years or older, without specified prostate cancer at enrollment
400 IU——
Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study
2014 · α-tocopherol · Finnish male smokers aged 50–69 at baseline without self-reported cirrhosis
50 mg2922 days—
Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT
2016 · vitamin E alone · Caucasian men without prostate cancer at baseline, included in the SELECT analysis
400 IU——
Vitamin E administration may decrease the incidence of pneumonia in elderly males
2016 · AT (vitamin E) · Finnish males aged 50–69 at entry who smoked at least 5 cigarettes per day and started smoking at age 21 or older; the analysis subgroup included men who smoked 5–19 cigarettes per day and exercised at leisure at baseline
50 mg8 years—
Effects of vitamin C supplementation on gout risk: results from the Physicians' Health Study II trial
2022 · vitamin E assignment · Male physicians; mean age 64 ± 9 years
200 IU10 years—
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study
1995 · alpha-tocopherol · Male cigarette smokers aged 50–69 years
50 mg8 years—
Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
1993 · active tocopherol and deprenyl placebo · Patients with early, otherwise untreated Parkinson's disease
2,000 IU426 days—
Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
1993 · both active drugs · Patients with early, otherwise untreated Parkinson's disease
2,000 IU426 days—
Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group
1996 · tocopherol treatment · Untreated patients with Parkinson's disease
2 g——
Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group
1996 · deprenyl and tocopherol treatment · Untreated patients with Parkinson's disease
2 g——
Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial
1996 · alpha tocopherol group · Men aged 50–69 who smoked and were free of known coronary heart disease at baseline
50 mg1716 days—
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance
1996 · alpha-tocopherol · Men aged 50–69 years who smoked at least five cigarettes daily
50 mg2227 days—
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
1997 · alpha-tocopherol (vitamin E) · Patients with moderately severe Alzheimer's disease; age and sex not stated
2,000 IU2 years—
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
1997 · selegiline and alpha-tocopherol · Patients with moderately severe Alzheimer's disease; age and sex not stated
2,000 IU2 years—
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial
1998 · alpha-tocopherol · Male smokers aged 50–69 years
50 mg2228 days—
[Gujing Maisiha Tablets combined with natural vitamin E for the treatment of idiopathic asthenospermia]
2017 · treatment group · Men aged 22–44 with idiopathic asthenospermia
200 mg90 days65
Tocotrienol-Rich Vitamin E (Tocovid) Improved Nerve Conduction Velocity in Type 2 Diabetes Mellitus Patients in a Phase II Double-Blind, Randomized Controlled Clinical Trial
2021 · Tocovid group · Adults aged 35–75 with type 2 diabetes mellitus and stable glycaemic control; the study did not require diagnosed diabetic peripheral neuropathy
400 mg1 year44
The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial
2020 · Tocovid group · Adults aged 35–75 with type 2 diabetes mellitus and HbA1c of 6% to 9%, with or without diabetic peripheral neuropathy symptoms
400 mg8 weeks40
Comparative effectiveness of B and e vitamins with diclofenac in reducing pain due to osteoarthritis of the knee
2015 · Vitamin E group · Adults aged 30–60 with primary knee osteoarthritis; the reported age range in this arm was 30–60 years
100 mg3 weeks35
Oral Omega-3 Fatty Acid Supplementation for Laser In Situ Keratomileusis-Associated Dry Eye
2017 · control group · Patients undergoing LASIK
400 mg13 weeks30
Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial
2017 · group A · Patients with differentiated thyroid cancer undergoing postsurgical radioiodine ablation
100 mg5 weeks23
The Influence of Vitamin E and Omega-3 Fatty Acids on Reproductive Health Indices Among Male Workers Exposed to Electromagnetic Fields
2022 · Vitamin E group · Male workers aged 20–50 years employed for at least 2 years and exposed to electromagnetic fields; no stated fertility diagnosis
100 mg90 days22
[Photodynamic therapy for age related macular degeneration with and without antioxidants]
2002 · Antioxidants · Adults aged 55 to 86 years with bilateral age-related macular degeneration and neovascular membranes
200 mg—20
Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children
2008 · Group 3 · Obese children aged 10–17 years with non-alcoholic fatty liver disease
100 mg30 days19
Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial
2010 · vitamin E group (group 1) · Patients receiving cisplatin chemotherapy; age and sex not specified.
400 mg—17
γ-Tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation
2013 · γ-T-rich supplementation · Otherwise healthy smokers, mean age 22 ± 1 years, quitting smoking
500 mg7 days16
A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps
2001 · vitamin E · haemodialysis patients with end-stage renal disease; age and sex not specified
400 mg8 weeks15
Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial
2012 · vitamin E (400 mg) and placebo · Hemodialysis patients with restless legs syndrome
400 mg8 weeks15
Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial
2017 · group C · Patients with differentiated thyroid cancer undergoing postsurgical radioiodine ablation
300 mg5 weeks15
Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial
2016 · group 1 · Patients with solid malignancies starting cisplatin; ages and sex not reported
400 mg90 days13
Effect of antioxidant vitamin supplementation on muscle function after eccentric exercise
1993 · vitamin E · physically active young subjects
400 mg4 weeks8
Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons
1999 · 100-mg vitamin E group · Healthy, noninstitutionalized adults aged 65–80 years
100 mg26 weeks—
Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis
2000 · combination of vitamins E and C · Smoking and nonsmoking men and postmenopausal women aged 45–69 years with serum cholesterol ≥5.0 mmol/L
182 mg3 years—
Lipid peroxide, beta-carotene and alpha-tocopherol in ischaemic stroke and effect of exogenous vitamin E supplementation on outcome
1997 · vitamin E group · Adults with CT-proven ischemic stroke presenting within 24 hours; ages and sex not specified
300 mg15 days—
Arterial compliance and vitamin E blood levels with a self emulsifying preparation of tocotrienol rich vitamin E
2008 · 100 mg SF-TRE group · healthy adult males
100 mg60 days—
Effect of conjugated linoleic acids, vitamin E and their combination on the clinical outcome of Iranian adults with active rheumatoid arthritis
2009 · group E · Adults with active rheumatoid arthritis
400 mg90 days—
Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients
2012 · TCP supplementation · Adults, including healthy participants and surgical patients; prospective liver-transplantation patients were included
400 mg20 weeks—
Vitamin E supplementation, superoxide dismutase status, and outcome of scaling and root planing in patients with chronic periodontitis: a randomized clinical trial
2014 · Treatment group 2 (TG-2) · Patients with chronic periodontitis; age and sex not reported
100 mg90 days—
Vitamin C and E supplementation hampers cellular adaptation to endurance training in humans: a double-blind, randomised, controlled trial
2014 · vitamin C and E group · young men and women undergoing endurance training; age range and health condition not stated
235 mg11 weeks—
Vitamin C and E supplementation blunts increases in total lean body mass in elderly men after strength training
2016 · antioxidant group · Men aged 60–81 years participating in strength training
235 mg12 weeks—
Reduction of disease activity in rheumatoid arthritis by tocotrienol-rich fraction supplementation: a randomized, double-blind, placebo-controlled trial
2025 · Tocotrienol-rich fraction (TRF) group · Adults with moderate-to-severe active rheumatoid arthritis
400 mg26 weeks—
Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina
1998 · vitamin E · Patients with coronary spastic angina; age and sex not specified
300 mg30 days—
Prenatal vitamin C and E supplementation in smokers is associated with reduced placental abruption and preterm birth: a secondary analysis
2015 · Vitamin C and E supplementation · Pregnant low-risk nulliparous women with singleton gestations; the reported subgroup analysis included women who smoked during pregnancy
400 IU—4,993
Vitamin C and E supplementation to prevent spontaneous preterm birth: a randomized controlled trial
2010 · vitamin C and E supplementation · Low-risk nulliparous women with singleton pregnancies, enrolled at 9 weeks 0 days to 16 weeks 6 days of gestation
400 IU—4,992
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico
1999 · n-3 PUFA and vitamin E · Patients who survived a recent myocardial infarction (within 3 months); age and sex not specified
300 mg1278 days2,830
Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial
2004 · E group · Nursing home residents aged 65 years or older; no specific diagnosed condition required
200 IU1 year311
Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori
2012 · Group A · Patients with Helicobacter pylori infection
400 IU30 days160
Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori
2012 · Group A · Patients with Helicobacter pylori infection
400 IU30 days160
Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial
1999 · vitamin group · Women at increased risk of pre-eclampsia, enrolled at 16–22 weeks’ gestation
400 IU—141
CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study
2015 · DHA group · Adults aged 55–85 with early AMD in the study eye and neovascular AMD in the fellow eye
6 mg3 years127
A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement
2013 · supplemented group · Patients scheduled for on-pump cardiac surgery; age and sex not specified
400 IU—103
Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate?
2009 · group B · Patients with Helicobacter pylori infection; age range and sex not reported
400 IU30 days80
Efficacy of vitamins supplementation to therapy on Helicobacter pylori eradication in patients with low antioxidant capacity
2011 · Group A · Patients with H. pylori-positive nonulcer dyspepsia, chronic stress, and low total antioxidant capacity
400 IU30 days80
Selenium and Vitamin E for Prevention of Non-Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial
2023 · selenium and vitamin E · Adults aged 18 years or older with newly diagnosed, pathologically confirmed non-muscle-invasive bladder cancer
200 IU548 days69
Role of vitamin E and D(3) supplementation in Intra-Cytoplasmic Sperm Injection outcomes of women with polycystic ovarian syndrome: A double blinded randomized placebo-controlled trial
2017 · treatment group · Infertile women with PCOS scheduled for ICSI; age and sex beyond women not specified
400 mg8 weeks52
Beneficial effect of l-arginine in women using assisted reproductive technologies: a small-scale randomized controlled trial
2020 · AS2000 group · Women aged under 40 undergoing assisted reproductive technology treatment and planning egg retrieval for embryo transfer
10 mg90 days36
[Alcohol-induced toxic hepatitis--a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy]
1993 · antioxidant group · Patients with acute alcohol-toxic hepatitis, clinical Child/Pugh severity grades B and C; age and sex not reported
600 mg—31
Recombinant human erythropoietin in the treatment of anemia of prematurity
1995 · Group A · Premature infants with birthweight ≤1.75 kg, gestational age ≤33 weeks, and anemia (hemoglobin <10 g/dL and hematocrit <30%)
5 mg/kg4 weeks26
Recombinant human erythropoietin in the treatment of anemia of prematurity
1995 · Group B · Premature infants with birthweight ≤1.75 kg, gestational age ≤33 weeks, and anemia (hemoglobin <10 g/dL and hematocrit <30%)
5 mg/kg4 weeks25
Recombinant human erythropoietin in the treatment of anemia of prematurity
1995 · Group C · Premature infants with birthweight ≤1.75 kg, gestational age ≤33 weeks, and anemia (hemoglobin <10 g/dL and hematocrit <30%)
5 mg/kg4 weeks19
Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial
1999 · group C · Interferon-naive patients with chronic hepatitis C; age and sex not reported
544 IU24 weeks8
MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
1999 · antioxidant vitamin supplement · Men and women aged 40–80 at elevated risk of coronary heart disease death due to prior coronary heart disease, occlusive non-coronary arterial disease, diabetes mellitus, or treated hypertension
600 mg5 years—
The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers
1999 · both AT and BC · middle-aged male smokers
50 mg——
Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers
2000 · alpha-tocopherol and beta-carotene · Men aged 50 to 69 who smoked cigarettes and had no history of stroke
50 mg6 years—
Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
2000 · alpha tocopherol and beta carotene · Men aged 50–69 who smoked and were included in the high-risk-for-stroke subgroup analysis
50 mg6 years—
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
400 IU8 years—
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants alone · Adults aged 55–81 years with age-related macular degeneration categories 1–4 or other AREDS ocular eligibility; participants in AMD categories 2–4 were eligible for this arm, and category 1 participants could also receive antioxidants
400 IU339 weeks—
Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study
2004 · alpha-tocopherol plus beta-carotene · men aged 50–69 who smoked
50 mg8 years—
Vitamins C and E in the latency period in women with preterm premature rupture of membranes
2005 · vitamin C and vitamin E · Women with singleton pregnancies at 26 to 34 weeks' gestation and PPROM
400 IU——
Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial
2005 · antioxidant vitamins · Adults with acute myocardial infarction; mean age 62 years
600 mg30 days—
Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients
2006 · supplement arm · Head and neck cancer patients treated by radiation therapy
400 IU——
Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial
2007 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 years, free of cancer at baseline
50 mg2227 days—
Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake
2008 · Vitamin E and beta-carotene · Males aged 50–69 years who smoked at baseline and had no tuberculosis diagnosis before randomisation
50 mg2228 days—
Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C
2009 · vitamin E + β-carotene · men aged 50–69 years who smoked at least 5 cigarettes per day
50 mg8 years—
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial
2009 · Factor D · Adults in Linxian, China; age and sex details not given
30 mg313 weeks—
Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival
2009 · α-tocopherol and β-carotene · Caucasian male smokers aged 50–69 years; prostate cancer cases were analysed in this report
50 mg8 years—
Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial
2011 · daily combination of atorvastatin, vitamin C, and vitamin E · Men and women aged 50–70 years; healthy individuals, including a subgroup with NAFLD at baseline
1,000 IU1314 days—
Effect of intramuscular vitamin E on mortality and intracranial hemorrhage in neonates of 1000 grams or less
1990 · Treatment group · Premature neonates weighing 501–1000 g and aged 24 hours or less
100 mg/kg6 days—
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
2011 · selenium plus vitamin E group · Healthy men at average risk of prostate cancer; age 50 or older for African Americans and 55 or older for others
400 IU2008 days—
Reduced mortality among children in southern India receiving a small weekly dose of vitamin A
1990 · treated group · Preschool-age children in southern India
2.86 mg1 year—
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT
2012 · selenium plus vitamin E · Men aged 50 years or older if Black and 55 years or older otherwise, without prior prostate cancer diagnosis
400 IU6 years—
Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis
2013 · combined β-carotene/α-tocopherol · Finnish male smokers aged 50–69
50 mg2227 days—
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
400 IU339 weeks—
Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
2014 · selenium plus vitamin E · African-American men aged 50 years or older and non-African-American men aged 55 years or older, without specified prostate cancer at enrollment
400 IU——
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
400 IU9 years—
Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study
2014 · α-tocopherol and β-carotene · Finnish male smokers aged 50–69 at baseline without self-reported cirrhosis
50 mg2922 days—
Vitamin E administration may decrease the incidence of pneumonia in elderly males
2016 · AT + BC (vitamin E + β-carotene) · Finnish males aged 50–69 at entry who smoked at least 5 cigarettes per day and started smoking at age 21 or older; the analysis subgroup included men who smoked 5–19 cigarettes per day and exercised at leisure at baseline
50 mg8 years—
The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
2020 · α-Tocopherol and β-carotene (AT + BC) · Male smokers aged 50–69 years who smoked at least 5 cigarettes per day at entry
50 mg2227 days—
Investigating the preventive effect of vitamins C and E on preeclampsia in nulliparous pregnant women
2020 · intervention group · Nulliparous pregnant women aged 18–38 years without risk factors for preeclampsia
400 IU——
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study
1995 · beta-carotene and alpha-tocopherol · Male cigarette smokers aged 50–69 years
50 mg8 years—
Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study
1994 · rHuEpo group · Preterm infants up to 32 weeks’ gestation, 2 to 8 weeks postnatal age, with central hematocrit ≤35% and anemia of prematurity
25 IU6 weeks—
Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study
1994 · Placebo group · Preterm infants up to 32 weeks’ gestation, 2 to 8 weeks postnatal age, with central hematocrit ≤35% and anemia of prematurity
25 IU6 weeks—
Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer
1993 · retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis
11.4 mg87 weeks—
Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16
1993 · Group 1 (vitamins) · Individuals after endoscopic polypectomy; age and sex not reported; adenomas were the condition of interest.
70 mg548 days—
Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial
1996 · alpha tocopherol plus beta carotene group · Men aged 50–69 who smoked and were free of known coronary heart disease at baseline
50 mg1716 days—
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance
1996 · alpha-tocopherol and beta-carotene · Men aged 50–69 years who smoked at least five cigarettes daily
50 mg2227 days—
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial
1997 · vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C was common at baseline
15 mg2 years—
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial
1998 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 years
50 mg2228 days—
A randomized controlled trial of vitamin E and selenium on rate of decline in lung function
2015 · Vitamin E · Men aged 50 years and older without clinical evidence of prostate cancer
400 IU5 years726
Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid
1998 · alpha-tocopherol supplementation · Male smokers aged 55–74 years
50 mg6 years191
Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial
2014 · alpha tocopherol plus memantine · Veterans with mild to moderate Alzheimer disease taking an acetylcholinesterase inhibitor; mean age 78.8 years, 97% men
2,000 IU4 years154
Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial
2014 · alpha tocopherol alone · Veterans with mild to moderate Alzheimer disease taking an acetylcholinesterase inhibitor; mean age 78.8 years, 97% men
2,000 IU4 years152
Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis
2019 · Vitamin E group, adults in PIVENS · Adults with biopsy-proven NASH, without diabetes or cirrhosis
800 IU96 weeks69
The effect of vitamin E on hot flashes in menopausal women
2007 · vitamin E therapy · Menopausal women with hot flashes
400 IU4 weeks51
Evaluation of dietary intake of vitamin E in the treatment of atopic dermatitis: a study of the clinical course and evaluation of the immunoglobulin E serum levels
2002 · VE group · People with atopic dermatitis; age and sex distribution not fully specified
400 IU240 days50
Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis
2019 · Vitamin E group, children in TONIC · Children with NAFLD, without diabetes
800 IU96 weeks48
Evaluation of the effect of vitamin E on pelvic pain reduction in women suffering from primary dysmenorrhea
2013 · study group · Women with primary dysmenorrhea
400 IU60 days42
[Effectiveness of vitamin E in comparison with diclofenac sodium in treatment of patients with chronic polyarthritis]
1998 · vitamin E group · Hospitalized patients with established chronic rheumatoid arthritis; age and sex not reported
1.2 g3 weeks42
δ-Tocotrienol in Combination with Resveratrol Improves the Cardiometabolic Risk Factors and Biomarkers in Patients with Metabolic Syndrome: A Randomized Controlled Trial
2023 · TRM · Adults aged 18–60 years with metabolic syndrome
500 mg24 weeks41
Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype
2011 · vitamin E treatment period, Hp 2-1 genotype · Adults with diabetes and the haptoglobin 2-1 genotype
400 IU90 days31
Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability
2016 · Group B (Peg-IFNα + RBV + Silybin, vitamin E, phospholipids) · Male and female adults with chronic hepatitis C receiving pegylated interferon-α and ribavirin
90 mg1 year31
Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients
2016 · alpha-tocopherol + omega-3 fatty acids placebo · Chronic hemodialysis patients; age and sex not specified
400 IU12 weeks30
The Effects of Magnesium and Vitamin E Co-Supplementation on Hormonal Status and Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome
2019 · magnesium plus vitamin E supplements · Women aged 18–40 years with polycystic ovary syndrome
400 mg12 weeks30
Effects of vitamins C and E supplementation combined with 12-week resistance training in older women with sarcopenia: A randomized, double-blind, placebo-controlled trial
2025 · Antioxidant supplementation group (AS) · Women aged 60–75 with sarcopenia; all participants had inadequate baseline vitamin C status, and most had inadequate vitamin E status.
335 mg12 weeks30
Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype
2011 · vitamin E treatment period, Hp 2-2 genotype · Adults with diabetes and the haptoglobin 2-2 genotype
400 IU90 days28
[High dosage vitamin E therapy in patients with activated arthrosis]
1990 · Vitamin E (V) · In-patients with osteoarthritis of the hip or knee
1.2 g3 weeks26
Vitamin E and fish oil, separately or in combination, on treatment of primary dysmenorrhea: a double-blind, randomized clinical trial
2018 · vitamin E · University students with primary dysmenorrhea
200 IU—25
Effect of vitamin E with and without saffron on the sexual function in women of reproductive age with sexual dysfunction: a randomized controlled trial
2024 · Vitamin E + placebo of saffron (control group) · Women aged 15–49 with sexual dysfunction and without severe or very severe depression or sleep disorders
50 mg8 weeks25
Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease
2003 · Vitamin E plus colchicine group · Patients aged 40–62 with early Peyronie's disease, penile deformity under 30 degrees, and no erectile dysfunction
600 mg26 weeks23
Gamma tocopherol effect on LPS-induced sputum neutrophilia is not modified by BMI or GSTM1 genotype
2019 · γT-enriched supplement · Adults with mild asthma, not using daily inhaled controller therapies; sex and age range not specified
1.2 g2 weeks23
The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial
2004 · vitamin E · Chinese inpatients with tardive dyskinesia
1,200 IU12 weeks22
Double-blind intervention trial on modulation of ozone effects on pulmonary function by antioxidant supplements
1999 · vitamin group · Dutch bicyclists; adults, with no stated medical condition, studied during exercise in ozone exposure
100 mg15 weeks20
Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients
2000 · Vit.E treatment · Adults with type II diabetes mellitus, free of diabetic complications; sex and age range not specified
600 mg8 weeks20
Muscle pains and biochemical changes following suxamethonium administration after six pretreatment regimens
1992 · alphatocopherol (vitamin E) · Patients receiving suxamethonium; age and sex not reported
600 mg—20
Systemic hypoxia enhances bactericidal activities of human polymorphonuclear leuocytes
2009 · vitamin E group · healthy sedentary men
1,000 IU1 day20
Water-soluble coenzyme Q10 formulation (Q-TER(®)) in the treatment of presbycusis
2010 · Group B · Patients with presbycusis; age and sex not reported
50 mg30 days20
Pharmacological doses of vitamin E and insulin action in elderly subjects
1994 · vitamin E · Elderly adults (mean age 77 years), nonobese, with normal glucose tolerance
900 mg120 days20
Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial
1997 · alpha-tocopherol · Patients with rheumatoid arthritis receiving anti-rheumatic drugs; age and sex not stated
1.2 g12 weeks20
Vitamin E and immunity after the Kona Triathlon World Championship
2004 · Vitamin E group · Triathletes competing in the Kona Triathlon World Championship; age and sex not reported
800 IU60 days19
Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?
2013 · vitamin E group · Patients with differentiated thyroid carcinoma undergoing ¹³¹I treatment
800 IU5 weeks19
Gamma tocopherol effect on LPS-induced sputum neutrophilia is not modified by BMI or GSTM1 genotype
2019 · γT-enriched supplement · Healthy volunteers; adults, sex and age range not specified
1.2 g7 days18
Vitamin E in the treatment of tardive dyskinesia
1993 · vitamin E group · Patients with tardive dyskinesia; age and sex not reported
1.2 g4 weeks17
A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia
1996 · vitamin E group · Patients with tardive dyskinesia; 29 had schizophrenia and 6 had a mood disorder
1,600 IU60 days17
A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps
2001 · combination of vitamins E and C · haemodialysis patients with end-stage renal disease; age and sex not specified
400 mg8 weeks15
Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial
2012 · vitamin C (200 mg) and vitamin E (400 mg) · Hemodialysis patients with restless legs syndrome
400 mg8 weeks15
Co-Administration of Vitamin E and Atorvastatin Improves Insulin Sensitivity and Peroxisome Proliferator-Activated Receptor-γ Expression in Type 2 Diabetic Patients: A Randomized Double-Blind Clinical Trial
2022 · atorvastatin with vitamin E (A+E) group · Women aged 18–65 with type 2 diabetes and hyperlipidemia
400 IU12 weeks15
Effect of coenzyme q10 on myopathic symptoms in patients treated with statins
2007 · vitamin E · Patients with statin-associated myopathic symptoms
400 IU30 days14
Dialysis leg cramps. Efficacy of quinine versus vitamin E
1992 · vitamin E · Patients on dialysis with a history of leg cramps
400 IU60 days13
Effects of vitamin E on chronic and acute endothelial dysfunction in smokers
2000 · vitamin E · healthy male smokers; mean age 28 ± 6 years
600 IU4 weeks11
Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis
2011 · group E · Patients with atopic dermatitis; age and sex not specified
600 IU60 days11
Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses
1998 · treatment group · Patients with tardive dyskinesia whose medication had been unchanged for at least 1 month
600 mg213 days11
Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study
1998 · vitamin E · People with type 2 diabetes and diabetic peripheral sensorimotor polyneuropathy
900 mg26 weeks11
Effect of vitamin E supplementation with exercise on cognitive functions and total antioxidant capacity in older people
2010 · V group (vitamin E group) · Sedentary adults aged 60–79 living in a retirement home, without medical illness or significant cognitive impairment
900 mg26 weeks10
Effect of vitamin E supplementation with exercise on cognitive functions and total antioxidant capacity in older people
2010 · EV group (vitamin E under training group) · Sedentary adults aged 60–79 living in a retirement home, without medical illness or significant cognitive impairment
900 mg26 weeks10
Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease
1998 · vitamin E · Adults with mild hypercholesterolaemia and angiographically documented coronary artery disease
400 IU8 weeks10
Attenuation of angiotensin converting enzyme inhibitor induced cough by iron supplementation: role of nitric oxide
2011 · anti-oxidant group · Patients with cough while receiving ACE-inhibitor therapy; age and sex not reported
200 mg4 weeks8
Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels
1999 · alpha-tocopherol group, high remnant lipoprotein levels · Patients with high serum remnant lipoprotein levels
300 IU4 weeks—
Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels
1999 · alpha-tocopherol group, low remnant lipoprotein levels · Patients with low serum remnant lipoprotein levels
300 IU4 weeks—
Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons
1999 · 50-mg vitamin E group · Healthy, noninstitutionalized adults aged 65–80 years
50 mg26 weeks—
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes
1999 · Vitamin E treatment · People with type 1 diabetes of less than 10 years’ duration and nondiabetic control subjects; ages and sex not stated
1,800 IU120 days—
The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial
1999 · alpha-tocopherol only · Male smokers aged 50–69 with intermittent claudication
50 mg193 weeks—
Vascular effects of estrogen and vitamin E therapies in postmenopausal women
1999 · vitamin E · healthy postmenopausal women
800 IU6 weeks—
Vascular effects of estrogen and vitamin E therapies in postmenopausal women
1999 · conjugated equine estrogens plus vitamin E · healthy postmenopausal women
800 IU6 weeks—
Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study
2000 · vitamin E therapy · Young subjects with type I diabetes mellitus
1,000 IU90 days—
Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes
2001 · vitamin E · Patients with type 2 diabetes and cardiac autonomic neuropathy; age and sex not reported.
600 mg120 days—
A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group
2001 · alpha-tocopherol group · Adults with ALS of less than 5 years' duration, treated with riluzole; age and sex not specified
1 g1 year—
UVB photoprotection with antioxidants: effects of oral therapy with d-alpha-tocopherol and ascorbic acid on the minimal erythema dose
2002 · Group 1 · Healthy volunteers
1,200 IU7 days—
Physical activity and the common cold in men administered vitamin E and beta-carotene
2003 · Vitamin E only · Men aged 50–69 who smoked; common-cold risk was assessed in physically active subgroups
50 mg2227 days—
Effect of vitamin E supplementation on the regular treatment of seasonal allergic rhinitis
2004 · vitamin E · Patients with documented hay fever (seasonal allergic rhinitis)
800 mg——
Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma
2005 · Antioxidants in addition to standard antiasthmatic therapy · Adults aged 25–50 with persistent mild to moderate bronchial asthma
400 mg16 weeks—
Arterial compliance and vitamin E blood levels with a self emulsifying preparation of tocotrienol rich vitamin E
2008 · 50 mg SF-TRE group · healthy adult males
50 mg60 days—
Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study
2010 · vitamin E · Women with premenstrual cyclical breast discomfort
1,200 IU26 weeks—
Effect of conjugated linoleic acids, vitamin E and their combination on the clinical outcome of Iranian adults with active rheumatoid arthritis
2009 · group CE · Adults with active rheumatoid arthritis
400 mg90 days—
Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects
1990 · vitamin E-supplemented group · healthy older adults; sex and exact age range not reported
800 mg30 days—
Atorvastatin improves erectile dysfunction in patients initially irresponsive to Sildenafil by the activation of endothelial nitric oxide synthase
2013 · vitamin E group · Patients with erectile dysfunction initially irresponsive to sildenafil; age and sex details not stated
400 IU6 weeks—
The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial
2014 · antioxidant supplementation · Adults aged 60–75 years with mild cognitive impairment
300 mg1 year—
Vitamin e supplementation, lung functions and clinical manifestations in children with moderate asthma: a randomized double blind placebo- controlled trial
2014 · case group · Children aged 5–17 years with moderate asthma
50 mg8 weeks—
Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: a randomized, single-blind, placebo-controlled trial
2013 · vitamin E group · Adults with type 2 diabetes; age and sex not specified
400 IU6 weeks—
Short term effects of palm-tocotrienol and palm-carotenes on vascular function and cardiovascular disease risk: A randomised controlled trial
2016 · TRF-80 · Men and women aged 18–70 years with type 2 diabetes, impaired fasting glucose and/or elevated waist circumference, at increased risk of impaired vascular function
552 mg8 weeks—
The effect of oral capsule of curcumin and vitamin E on the hot flashes and anxiety in postmenopausal women: A triple blind randomised controlled trial
2020 · vitamin E group · Postmenopausal women; mean age 51.7 years
200 IU8 weeks—
Effects of coadministration of DHA and vitamin E on spermatogram, seminal oxidative stress, and sperm phospholipids in asthenozoospermic men: a randomized controlled trial
2020 · EP group · Men aged 20–45 with idiopathic asthenozoospermia and normal endocrine function
600 IU12 weeks—
Curcumin and vitamin E improve hot flashes, lipid profile, and fasting blood glucose without any detrimental effect on the liver and renal function in postmenopausal women: A triple-blind placebo-controlled clinical trial
2024 · Vitamin E group · Postmenopausal women
400 IU8 weeks—
Randomized Clinical Trial of Antioxidant Therapy Patients with Septic Shock and Organ Dysfunction in the ICU: SOFA Score Reduction by Improvement of the Enzymatic and Non-Enzymatic Antioxidant System
2023 · Group 2 (Vit E) · Adults older than 18 years of any gender with septic shock admitted to the ICU
1,200 IU5 days—
Impact of Treatment with Antioxidants as an Adjuvant to Standard Therapy in Patients with Septic Shock: Analysis of the Correlation between Cytokine Storm and Oxidative Stress and Therapeutic Effects
2023 · Group 2 (Vit E) · Adults over 18 years of any gender with septic shock
1,200 IU5 days—
"Evaluation of Curcuma zedoaria Rosc. in the management of non-alcoholic fatty liver Disease: A Randomized, single blind, controlled trial"
2025 · control group · Patients with grade 1 (mild) or grade 2 (moderate) non-alcoholic fatty liver disease; ages and sex not reported
800 mg60 days—
Effect of vitamin E supplementation on recovery and recurrence prevention in women with lower urinary tract infections: A triple-blind randomized clinical trial
2026 · intervention group · Women over 18 years old with lower urinary tract infection
100 IU26 weeks—
A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility
1995 · Vitamin E (order A) · Men with high levels of reactive oxygen species generation in semen and a normal female partner
600 mg90 days—
The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group
1994 · tocopherol · patients with early untreated Parkinson's disease
2,000 IU426 days—
The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group
1994 · deprenyl and tocopherol · patients with early untreated Parkinson's disease
2,000 IU426 days—
Vitamin E treatment of tardive dyskinesia
1993 · Vitamin E · Patients with tardive dyskinesia
1,600 IU12 weeks—
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa
1993 · Vitamin E · Patients aged 18 through 49 years with retinitis pigmentosa
400 IU6 years—
Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial
1997 · 60 mg/d vitamin E group · Healthy free-living adults aged 65 years or older
60 mg235 days—
Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial
1997 · 800 mg/d vitamin E group · Healthy free-living adults aged 65 years or older
800 mg235 days—
Prospective evaluation of vitamin E for hot flashes in breast cancer survivors
1998 · vitamin E phase · Breast cancer survivors; age and sex not specified
800 IU4 weeks—
[Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance]
1998 · vitamin E group · Normal volunteers and patients with ischemic heart disease; age and sex not reported
600 mg6 days—
Long-term treatment effects of vitamin E for tardive dyskinesia
1998 · d-vitamin E · Patients with tardive dyskinesia on stable oral medications
1,600 IU36 weeks—
High doses of vitamin C plus E reduce strength training-induced improvements in areal bone mineral density in elderly men
2017 · antioxidant group (AO) · Healthy elderly men; age range not reported (mean age 70 ± 7 years)
235 mg12 weeks16
The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
2007 · RRR-alpha-tocopherol · Individuals with type 2 diabetes; age and sex not specified
500 mg6 weeks—
The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
2007 · mixed tocopherols · Individuals with type 2 diabetes; age and sex not specified
500 mg6 weeks—
Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial
2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India
7.5 mg1 year316
Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial
2013 · active compound · Patients who had undergone polypectomy and were undergoing post-polypectomy endoscopic follow-up
30 mg5 years164
Effects of perioperative vitamin E and zinc co-supplementation on systemic inflammation and length of stay following coronary artery bypass graft surgery: a randomized controlled trial
2024 · intervention group · Patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass; age and sex not reported
200 IU3 weeks40
Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly
2004 · special nutritional formula · Healthy adults aged 70 years or older with Mini Mental score ≥22
120 IU1 year30
"The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants
1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition
30 mg8 years—
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
400 IU8 years—
Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren
2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified
8 mg335 days—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
10 mg——
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility
400 IU339 weeks—
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals
2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population
30 mg2739 days—
Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?
2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
30 mg2739 days—
[The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health]
2006 · antioxidant supplementation · Middle-aged adults in the general population
30 mg2738 days—
Antioxidant supplementation increases the risk of skin cancers in women but not in men
2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial
30 mg2738 days—
Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study
2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years
30 mg2738 days—
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
400 IU339 weeks—
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38
2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years
400 IU9 years—
Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women
2014 · multivitamins without vitamin A · HIV-infected pregnant women in Tanzania
30 mg1249 days—
Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women
2014 · multivitamins with vitamin A · HIV-infected pregnant women in Tanzania
30 mg1249 days—
Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer
1993 · riboflavin plus retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis
11.4 mg87 weeks—
Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial
1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline
15 mg2 years—
Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants
1998 · active medication · Adults with colorectal polyps; age range and sex not stated
75 mg3 years—
Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial
2015 · supplemented group · Adults with facioscapulohumeral muscular dystrophy (FSHD)
400 mg17 weeks26
A randomized controlled trial of vitamin E and selenium on rate of decline in lung function
2015 · Vitamin E and Selenium · Men aged 50 years and older without clinical evidence of prostate cancer
400 IU5 years709
Sesame Lignans and Vitamin E Supplementation Improve Subjective Statuses and Anti-Oxidative Capacity in Healthy Humans With Feelings of Daily Fatigue
2015 · SVE group · Healthy men and women aged 30–69 who reported daily fatigue
55 mg8 weeks154
Antioxidant supplementation reduces endometriosis-related pelvic pain in humans
2013 · Group A · Women aged 19–41 with pelvic pain and a history of endometriosis and/or infertility
1,200 IU8 weeks46
Single dose vitamin A treatment in acute shigellosis in Bangladesh children: randomised double blind controlled trial
1998 · Vitamin A group · Children aged 1–7 years with bacteriologically proven acute shigellosis and no clinical signs of vitamin A deficiency
25 IU1 day42
Effects of antioxidant vitamins C and E on signal-averaged electrocardiogram in acute myocardial infarction
1996 · supplemented group · Patients with acute myocardial infarction
600 mg2 weeks33
Does vitamin C or its combination with vitamin E improve radial artery endothelium-dependent vasodilatation in patients awaiting coronary artery bypass surgery?
2013 · vitamins C + E group (group 2) · Adults with angiographically confirmed significant coronary artery disease awaiting coronary artery bypass surgery
600 IU1 day31
Vitamin E and ginseng supplementation to enhance female sexual function: a randomized, double-blind, placebo-controlled, clinical trial
2020 · supplement group · Women with sexual dysfunction, age range not reported
100 IU6 weeks31
Acute autonomic effects of vitamins and fats in male smokers
2009 · moderate vitamins · Male smokers, mean age 34.2 years (SD 6.9)
75 IU1 day30
Acute autonomic effects of vitamins and fats in male smokers
2009 · high doses of vitamins · Male smokers, mean age 34.2 years (SD 6.9)
800 IU1 day30
Effect of the omega-3 fatty acid plus vitamin E supplementation on subjective global assessment score, glucose metabolism, and lipid concentrations in chronic hemodialysis patients
2016 · omega-3 fatty acids + vitamin E · Chronic hemodialysis patients; age and sex not specified
400 IU12 weeks30
Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients
2016 · omega-3 fatty acids + alpha-tocopherol · Chronic hemodialysis patients; age and sex not specified
400 IU12 weeks30
The effects of magnesium and vitamin E co-supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial
2019 · magnesium plus vitamin E · Patients with grade 3 diabetic foot ulcer
400 IU12 weeks29
Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter
2013 · PTX and vitamin E treatment · Breast cancer patients with localized disease after breast/chest wall irradiation
400 IU26 weeks26
Randomized Trial of Vitamin C/E Complex for Prevention of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer
2016 · trial group · Patients with head and neck cancer receiving radiotherapy; age and sex not reported
200 IU—25
Vitamin E and fish oil, separately or in combination, on treatment of primary dysmenorrhea: a double-blind, randomized clinical trial
2018 · vitamin E-omega-3 · University students with primary dysmenorrhea
200 IU—25
Effect of vitamin E with and without saffron on the sexual function in women of reproductive age with sexual dysfunction: a randomized controlled trial
2024 · Saffron + Vitamin E (experimental group) · Women aged 15–49 with sexual dysfunction and without severe or very severe depression or sleep disorders
50 mg8 weeks25
Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents
1996 · First group: fish oil followed by placebo · Adolescent girls with dysmenorrhea
1.5 mg60 days21
Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents
1996 · Second group: placebo followed by fish oil · Adolescent girls with dysmenorrhea
1.5 mg60 days21
A randomised, double masked, clinical trial of high dose vitamin A and vitamin E supplementation after photorefractive keratectomy
2001 · vitamin treated group · patients who underwent myopic photorefractive keratectomy (PRK); age and sex not reported
230 mg360 days20
Protective effect of anti-oxidants on endothelial function in young Korean-Asians compared to Caucasians
2012 · antioxidant vitamins · Healthy Korean and Caucasian adults aged 20–35 years
800 IU2 weeks20
The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome
2018 · omega-3 fatty acids plus vitamin E · Women with polycystic ovary syndrome (PCOS)
400 IU12 weeks20
Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal
1997 · high-fat meal with vitamins · Healthy, normocholesterolemic men and women aged 24 to 54 years
800 IU1 day20
[Analysis on therapeutic effect of variable-frequency electroacupuncture combined with herbal-moxa moxibustion for post-zoster neuralgia]
2012 · medication group · Adults with herpes zoster regional neuralgia
200 mg7 days19
The Influence of Vitamin E and Omega-3 Fatty Acids on Reproductive Health Indices Among Male Workers Exposed to Electromagnetic Fields
2022 · Vitamin E + Omega-3 group · Male workers aged 20–50 years employed for at least 2 years and exposed to electromagnetic fields; no stated fertility diagnosis
100 mg90 days19
Vitamin E, γ-tocopherol, reduces airway neutrophil recruitment after inhaled endotoxin challenge in rats and in healthy volunteers
2013 · γT-enriched supplement · Healthy volunteers with negative methacholine challenge
1.66 g7 days17
Impairment of coronary circulation by acute hyperhomocysteinaemia and reversal by antioxidant vitamins
2004 · methionine load with antioxidant vitamins · Healthy volunteers aged 26–40 years; nine men and seven women, with no stated condition
800 IU1 day16
Effect of strength training combined with antioxidant supplementation on muscular performance
2018 · vitamins · Women, mean age 23.8 years, participating in strength training; no diagnosed condition stated
400 IU10 weeks15
Improved lung function following dietary antioxidant supplementation in exercise-induced asthmatics
2016 · Vitamins (V) · Adults with exercise-induced asthma (mean age 22.0 years) and healthy controls (mean age 28.2 years)
300 IU3 weeks13
Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements
1998 · supplementation group · Amateur cyclists; age and sex not reported; no condition stated
75 mg90 days12
Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis
2011 · group DE · Patients with atopic dermatitis; age and sex not specified
600 IU60 days11
Green tea and vitamin E enhance exercise-induced benefits in body composition, glucose homeostasis, and antioxidant status in elderly men and women
2013 · GTVE · Healthy elderly men and women; mean age 71.1 years
400 IU12 weeks11
Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal
1997 · low-fat meal with vitamins · A subgroup of healthy, normocholesterolemic men and women aged 24 to 54 years
800 IU1 day10
Effect of vitamin supplementation on lung injury and running performance in a hot, humid, and ozone-polluted environment
2011 · Vitamin trial · Runners; age, sex, and health condition not specified
100 IU2 weeks9
The effects of acute oral antioxidants on diving-induced alterations in human cardiovascular function
2007 · acute antioxidants · Experienced divers; age and sex not reported
400 IU1 day6
Effects of micronutrient antioxidants (alpha-tocopherol and ascorbic acid) on skin thickening and lung function in patients with early diffuse systemic sclerosis
2011 · Subgroup A · Patients with early diffuse systemic sclerosis, positive anti-topoisomerase-I antibody, high skin thickening progression rate and decreased lung diffusing capacity; age and sex not reported
400 IU26 weeks6
The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial
1999 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 with intermittent claudication
50 mg193 weeks—
Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans
2000 · Carotenoid supplement plus vitamin E · Healthy volunteers
335 mg12 weeks—
The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract
2002 · vitamin group · Adult American and English outpatients with early age-related cataract
600 mg3 years—
UVB photoprotection with antioxidants: effects of oral therapy with d-alpha-tocopherol and ascorbic acid on the minimal erythema dose
2002 · Group 3 · Healthy volunteers
1,200 IU7 days—
Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants
2002 · vitamin supplement group · Children with asthma living in Mexico City; age and asthma severity not specified
50 mg——
Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study
2003 · supplemented group · Men and postmenopausal women aged 45–69 years, smoking or nonsmoking, with serum cholesterol ≥5.0 mmol/L
272 IU6 years—
Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus
2003 · oral antioxidant therapy · People with Type 1 or Type 2 diabetes and matched healthy control subjects; ages and sex not reported
800 IU26 weeks—
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial
2003 · antioxidant vitamin therapy · children with familial hypercholesterolemia or the phenotype of familial combined hyperlipidemia
400 IU6 weeks—
Physical activity and the common cold in men administered vitamin E and beta-carotene
2003 · Vitamin E and beta-carotene · Men aged 50–69 who smoked; common-cold risk was assessed in physically active subgroups
50 mg2227 days—
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
2003 · vitamins E and C · Patients with nonalcoholic steatohepatitis (NASH); age and sex not specified
1,000 IU26 weeks—
Effects of dietary supplementation with vitamins C and E on muscle function during and after eccentric contractions in humans
2004 · treatment group · male volunteers; no age range or diagnosed condition reported
1,200 IU37 days—
Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients
2005 · supplement arm · Head and neck cancer patients receiving radiation therapy; age and sex not stated
400 IU3 years—
Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients
2009 · EP1 · Patients with severe erythrodermic psoriasis
50 mg30 days—
Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients
2009 · PsA1 · Patients with severe arthropathic psoriasis
50 mg5 weeks—
Vitamin E and evening primrose oil for management of cyclical mastalgia: a randomized pilot study
2010 · vitamin E plus EPO · Women with premenstrual cyclical breast discomfort
1,200 IU26 weeks—
Improvement of major depression is associated with increased erythrocyte DHA
2013 · HiDHA · Adults receiving treatment for major depression
10 mg16 weeks—
Antioxidants improve vascular function in children conceived by assisted reproductive technologies: A randomized double-blind placebo-controlled trial
2015 · Antioxidant vitamins · Children conceived by assisted reproductive technology (ART)
400 IU4 weeks—
Antioxidants improve vascular function in children conceived by assisted reproductive technologies: A randomized double-blind placebo-controlled trial
2015 · Antioxidant vitamins · Control children (children not conceived by assisted reproductive technology)
400 IU4 weeks—
Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction
2016 · HA group (high ascorbate, >1 mmol/l) · Patients of either sex with a first ST-segment elevation myocardial infarction undergoing primary percutaneous coronary angioplasty
400 IU12 weeks—
Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction
2016 · LA group (low ascorbate, <1 mmol/l) · Patients of either sex with a first ST-segment elevation myocardial infarction undergoing primary percutaneous coronary angioplasty
400 IU12 weeks—
Mechanical Ventilation Antioxidant Trial
2015 · vitamin C plus vitamin E · critically ill adults requiring mechanical ventilation
3,000 IU——
Mechanical Ventilation Antioxidant Trial
2015 · vitamin C plus vitamin E plus N-acetylcysteine · critically ill adults requiring mechanical ventilation
3,000 IU——
Effects of coadministration of DHA and vitamin E on spermatogram, seminal oxidative stress, and sperm phospholipids in asthenozoospermic men: a randomized controlled trial
2020 · DE group · Men aged 20–45 with idiopathic asthenozoospermia and normal endocrine function
600 IU12 weeks—
An Examination into the Effects of a Nutraceutical Supplement on Cognition, Stress, Eye Health, and Skin Satisfaction in Adults with Self-Reported Cognitive Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial
2024 · nutraceutical group · Healthy males and females aged 40–75 with self-reported memory complaints
12 mg12 weeks—
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa
1993 · Vitamin A plus vitamin E · Patients aged 18 through 49 years with retinitis pigmentosa
400 IU6 years—
Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E)
1998 · vitamins C and E · Human subjects; age, sex, and health status not specified; assessed for sunburn response
1,000 IU8 days—
Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone
1998 · supplement group · Mexico City street workers exposed to high ozone levels; age and sex not stated
75 mg26 weeks—
Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation
1998 · Group (3) · Healthy volunteers
2 g50 days—
The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes
2004 · group V · People with type 2 diabetes; age and sex not reported
150 mg90 days18
Vitamin E can reduce blood pressure in mild hypertensives
2002 · drug group (DG) · Adults aged 20–60 with mild hypertension and no other cardiovascular risk factors
200 IU27 weeks—
Vitamin E differentially affects short term exercise induced changes in oxidative stress, lipids, and inflammatory markers
2012 · vitamin E · Sedentary, otherwise healthy adults: women aged 18–55 and men aged 18–50
800 IU8 weeks—
Perturbation of cellular immune functions in cigarette smokers and protection by palm oil vitamin E supplementation
2013 · Smokers receiving palmvitee · Healthy male cigarette smokers aged 20–50 years; smoking for at least 5 years and at least 10 cigarettes daily
200 mg24 weeks30
Perturbation of cellular immune functions in cigarette smokers and protection by palm oil vitamin E supplementation
2013 · Nonsmokers receiving palmvitee · Healthy male nonsmokers aged 20–50 years
200 mg24 weeks29
Effects of gamma-tocopherol supplementation on thrombotic risk factors
2007 · 200 mg/day gamma-T group · Healthy subjects; age and sex not reported
200 mg5 weeks13
Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations
1996 · A: RRR-alpha-tocopherol · Patients aged 0.7–29.8 years with cystic fibrosis
268 mg6 weeks10
Plasma vitamin C and tocotrienols changes in response to dietary supplementation among young male adults
2010 · Tocotrienol · young male police recruits
200 mg8 weeks—
Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities
1996 · 200 mg/day alpha-tocopherol group · healthy volunteers; age and sex not stated
200 mg4 weeks—
Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial
2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering
7.5 mg1 year316
Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial
2017 · PCSO-524® · Children and adolescents aged 6–14 years with elevated ADHD symptoms, including participants with and without an ADHD diagnosis
675 mcg14 weeks74
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · NF group, 3-month blinded trial · Community-dwelling adults aged 18–86 years, both sexes, without dementia or clinical memory difficulties
30 IU90 days59
Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study
2014 · Test group 1 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m²
250 mg14 weeks55
Wrinkle reduction in post-menopausal women consuming a novel oral supplement: a double-blind placebo-controlled randomized study
2014 · Test group 2 · Healthy, non-smoking post-menopausal women, skin types I–III, not receiving HRT and with BMI 18–33 kg/m²
30 mg14 weeks55
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
2015 · ω-3 PUFA group · People aged 13–25 with ultra-high risk for psychosis
7.6 mg12 weeks40
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · Open-label NF group, separate 6-month trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties
30 IU26 weeks38
A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study
2019 · verum group · Women aged 35–73 with healthy skin
2.3 mg12 weeks36
Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
2024 · 10-element combination tablet · Overweight or obese adults with type 2 diabetes and mild-to-moderate painful diabetic neuropathy; mean age 63 years
15 mg26 weeks36
Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study
2006 · Colostrum + Micronutrients · Healthy, non-smoking men and women aged 40–80 years
200 mg10 weeks35
[Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis]
2004 · Karinat · Patients with chronic multifocal atrophic gastritis
10 mg26 weeks34
[Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease]
2004 · Karinat · Patients with benign breast disease, including mastopathy
10 mg26 weeks33
Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study
2006 · Micronutrients · Healthy, non-smoking men and women aged 40–80 years
200 mg10 weeks31
Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training
2011 · Nutrients (active treatment) · Normally hearing Swedish military personnel, officers and military academy trainees, ages 18 and older, undergoing weapons training
305 mg2 days31
A Dermonutrient Containing Special Collagen Peptides Improves Skin Structure and Function: A Randomized, Placebo-Controlled, Triple-Blind Trial Using Confocal Laser Scanning Microscopy on the Cosmetic Effects and Tolerance of a Drinkable Collagen Supplement
2020 · test product (Elasten) · Women aged 40–70 years; healthy, without a stated skin disease
2.3 mg12 weeks30
Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial
2022 · active group · Cognitively healthy adults aged 65 years and older
15 mg2 years30
The Effects of Specific Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins on Gait and Functional Capacity Parameters in Patients with Relapsing-Remitting Multiple Sclerosis
2021 · OMEGA group · Adults with relapsing-remitting multiple sclerosis; mean age 38.4 years (SD 7.1)
782 mg2 years27
EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors
2003 · PUFA supplement group · Children with ADHD-like symptoms who also reported thirst and skin problems; age and sex not stated
24 mg120 days25
Effect of γ-tocopherol supplementation on premenstrual symptoms and natriuresis: a randomized, double-blind, placebo-controlled study
2023 · γ-Toc intake · Healthy Japanese women aged 20–40 with cyclical water-retention symptoms during the luteal phase
386 mg7 days25
Gamma tocopherol-enriched supplement reduces sputum eosinophilia and endotoxin-induced sputum neutrophilia in volunteers with asthma
2018 · γT treatment · Adults aged 18–50 with mild intermittent or mild persistent asthma
1.31 g2 weeks23
The Effects of a 6-Month High Dose Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins Supplementation on Cognitive Function and Functional Capacity in Older Adults with Mild Cognitive Impairment
2020 · omega supplementation group · Adults aged 65 years or older with mild cognitive impairment
782 mg26 weeks23
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins
1999 · Methionine load with antioxidant vitamins · Healthy adults aged 25 to 45 years; 10 men and 10 women
800 IU1 day20
Neuroaspis PLP10™, a nutritional formula rich in omega-3 and omega-6 fatty acids with antioxidant vitamins including gamma-tocopherol in early Parkinson's disease: A randomized, double-blind, placebo-controlled trial
2021 · Neuroaspis PLP10™ · Patients with Parkinson's disease; age and sex not reported.
782 mg913 days20
Consumption of Nutritionally Enriched Hen Eggs Enhances Endothelium-Dependent Vasodilation via Cyclooxygenase Metabolites in Healthy Young People-A Randomized Study
2023 · Nutri4 (enriched eggs) · Healthy young adults aged 18–30 years, both sexes, with normal blood pressure and BMI
3.29 mg3 weeks20
Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year
2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years
30 mg1 year15
Effects of Supplementation with Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins, Combined with High-Intensity Functional Training, on Exercise Performance and Body Composition: A Randomized, Double-Blind, Placebo-Controlled Trial
2024 · experimental supplement group (SG) · Healthy young adult women and men, aged approximately 29 years, familiar with high-intensity functional training and with at least 6 months of similar exercise experience
782 mg8 weeks10
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
2010 · NF group, 2-week blinded trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties
30 IU2 weeks—
French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial
2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study
30 mg2922 days—
The impact of vitamins and/or mineral supplementation on blood pressure in type 2 diabetes
2004 · group MV · People with type 2 diabetes; age and sex not reported
150 mg90 days17
Effects of alpha-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes
2002 · alpha-tocopherol group · Korean patients with type 2 diabetes treated with continuous subcutaneous insulin infusion
200 mg60 days48
Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine production in the elderly
2009 · vitamin E · elderly men and women, mean age 83 years
182 mg1 year47
[Effect of compound danshen dripping pill on arterial intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus]
2010 · vitamin E group · Patients with newly diagnosed type 2 diabetes mellitus; age and sex not reported
200 mg548 days36
Effect of vitamins on the lipid profile of patients on regular hemodialysis
2000 · vitamin E · hemodialysis patients; age and sex not reported
200 mg90 days21
Response of hypercholesterolemic subjects to administration of tocotrienols
1995 · gamma-tocotrienol group · Hypercholesterolemic subjects; age and sex not specified
200 mg4 weeks16
Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee)
1991 · palmvitee · Hypercholesterolemic human subjects with serum cholesterol 6.21–8.02 mmol/L
200 mg8 weeks15
Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans
2000 · alpha-tocotrienyl acetate · People with hypercholesterolemia; age and sex not reported
250 mg8 weeks13
Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans
2000 · delta-tocotrienyl acetate · People with hypercholesterolemia; age and sex not reported
250 mg8 weeks13
Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans
2000 · gamma-tocotrienyl acetate · People with hypercholesterolemia; age and sex not reported
250 mg8 weeks12
Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects
2006 · CHD patients, 200 mg/day · 12 patients with coronary heart disease
200 mg3 weeks12
Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease
2007 · 200 mg/day vitamin E (E200) · Patients with stable COPD
200 mg12 weeks9
Vitamin E supplementation inhibits muscle damage and inflammation after moderate exercise in hypoxia
2016 · hypoxia after vitamin E supplementation · Nine volunteers; age and sex not reported; no diagnosed condition stated
250 mg1 day9
Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee)
1991 · gamma-tocotrienol · Hypercholesterolemic subjects with serum cholesterol greater than 7.84 mmol/L
200 mg4 weeks7
Alpha-tocopherol dietary supplement decreases titers of antibody against 5-hydroxymethyl-2'-deoxyuridine (HMdU)
1999 · 200 mg/day alpha-tocopherol group · Eligible subjects in a phase II chemoprevention trial; age, sex, and condition are not specified
200 mg4 weeks—
Long-term effects of vitamin E, vitamin C, and combined supplementation on urinary 7-hydro-8-oxo-2'-deoxyguanosine, serum cholesterol oxidation products, and oxidation resistance of lipids in nondepleted men
2000 · vitamin E · men described as nondepleted; age and condition not stated
182 mg3 years—
Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men
2001 · vitamin E group · Clinically healthy men with mild hypercholesterolemia and normal vitamin C and E levels
200 mg1 year—
Alpha tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy subjects
2006 · 268 mg/day AT · healthy adults; sex and age range not specified
268 mg4 weeks—
Effect of vitamin E on reperfusion injuries during reconstructive vascular operations on lower limbs
2010 · E-vitamin group · Patients with angiography-proven atherosclerotic femoral superficial (AFS) occlusion undergoing supragenual reconstruction; age and sex not stated
200 mg8 days—
Vitamin E supplementation protects erythrocyte membranes from oxidative stress in healthy Chinese middle-aged and elderly people
2012 · VE2 · Healthy adults aged 55–70 years
200 mg120 days—
Effects of delta-tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial
2021 · tocotrienol group · Adults with type 2 diabetes mellitus taking oral hypoglycemic agents; age and sex not reported
250 mg24 weeks—
A randomized, single-blind, placebo-controlled trial of the effects of 200 mg alpha-tocopherol on the oxidation resistance of atherogenic lipoproteins
1998 · RRR-alpha-tocopheryl acetate supplementation · Smoking men; age not reported
200 mg60 days—
Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients
2013 · TRF group · Adults aged 18 years or older receiving chronic hemodialysis for end-stage renal disease
220 mg16 weeks41
Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly
2010 · Tx1 · Older adults aged approximately 68 years, men and women, healthy or with controlled chronic disease
400 IU1 year30
Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly
2010 · Tx2 · Older adults aged approximately 69 years, men and women, healthy or with controlled chronic disease
400 IU1 year30
Cardiovascular effects of oral Supplementation of vitamin C, E and folic acid in young healthy males
2004 · vitamin intervention · 31 young healthy male adults; 14 received the vitamin intervention
800 mg12 weeks14
Effect of antioxidants combined to resistance training on BMD in elderly women: a pilot study
2009 · antioxidants · Postmenopausal women, mean age 66.1 years, described as healthy
600 mg26 weeks8
Effect of antioxidants combined to resistance training on BMD in elderly women: a pilot study
2009 · exercise and antioxidants · Postmenopausal women, mean age 66.1 years, described as healthy
600 mg26 weeks8
Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension
2008 · vitamins C+E · Men aged 35–60 with grade 1 essential hypertension, without obesity, dyslipidaemia or diabetes
400 IU8 weeks—
Alpha-tocopherol supplementation for men with existing coronary artery disease: a feasibility study
1999 · alpha-tocopherol group · male veterans with existing coronary artery disease
400 mg26 weeks27
Effect of Omega-3 and Vitamins E + C Supplements on the Concentration of Serum B-Vitamins and Plasma Redox Aminothiol Antioxidant Status in Elderly Men after Strength Training for Three Months
2016 · group III · Healthy men, mean age 60 ± 6 years, undertaking strength training
235 mg90 days16
Effects of gamma-tocopherol supplementation on thrombotic risk factors
2007 · 100 mg/day gamma-T group · Healthy subjects; age and sex not reported
100 mg5 weeks14
Effects of soy protein on levels of remnant-like particles cholesterol and vitamin E in healthy men
2001 · SPI with vitamin E · healthy men; age not reported
200 mg3 weeks12
Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects
2006 · CHD patients, 100 mg/day · 12 patients with coronary heart disease
100 mg3 weeks12
Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects
2006 · CHD patients, 400 mg/day · 12 patients with coronary heart disease
400 mg3 weeks12
Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects
2006 · Healthy subjects, 400 mg/day · 12 healthy subjects
400 mg3 weeks12
A randomized, crossover study to evaluate α-tocopherol bioavailability via a microemulsion gel or dry tablet delivery in healthy adults
2024 · microemulsion gel formula · Healthy adults; mean age 37.3 years
288 mg1 day12
A randomized, crossover study to evaluate α-tocopherol bioavailability via a microemulsion gel or dry tablet delivery in healthy adults
2024 · dry solid tablet · Healthy adults; mean age 37.3 years
288 mg1 day12
Pharmacokinetics and bioavailability of the RRR and all racemic stereoisomers of alpha-tocopherol in humans after single oral administration
1993 · RRR alpha-tocopherol · men; age and health condition not reported
400 mg1 day12
Pharmacokinetics and bioavailability of the RRR and all racemic stereoisomers of alpha-tocopherol in humans after single oral administration
1993 · all rac alpha-tocopherol · men; age and health condition not reported
400 mg1 day12
Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations
1996 · B: all-rac-alpha-tocopheryl acetate, fat-soluble preparation · Patients aged 0.7–29.8 years with cystic fibrosis
400 mg6 weeks10
Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations
1996 · C: all-rac-alpha-tocopheryl acetate, water-miscible preparation · Patients aged 0.7–29.8 years with cystic fibrosis
400 mg6 weeks9
The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix
2004 · toast with butter (17.5 g fat) · Eight healthy individuals; age and sex not stated
150 mg1 day8
The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix
2004 · cereal with full-fat milk (17.5 g fat) · Eight healthy individuals; age and sex not stated
150 mg1 day8
The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix
2004 · cereal with semi-skimmed milk (2.7 g fat) · Eight healthy individuals; age and sex not stated
150 mg1 day8
The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix
2004 · water (0 g fat) · Eight healthy individuals; age and sex not stated
150 mg1 day8
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · olive oil (OO) · Healthy subjects; age and sex not specified
205 mg12 weeks—
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · safflower oil (SO) · Healthy subjects; age and sex not specified
205 mg12 weeks—
Bioavailability of vitamin E as function of food intake in healthy subjects: effects on plasma peroxide-scavenging activity and cholesterol-oxidation products
2001 · group A · Healthy Italian adults; age and sex not specified
300 mg15 days—
Bioavailability of vitamin E as function of food intake in healthy subjects: effects on plasma peroxide-scavenging activity and cholesterol-oxidation products
2001 · group B · Healthy Italian adults; age and sex not specified
300 mg15 days—
A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses
2002 · Alpha-tocopherol · Healthy men and women aged 25–45 years from five European regions
100 mg——
Vitamin C pharmacokinetics of plain and slow release formulations in smokers
2004 · Plain-release group · Healthy men aged 20–65 years who smoked at least 5 cigarettes per day
182 mg4 weeks—
Vitamin C pharmacokinetics of plain and slow release formulations in smokers
2004 · Slow-release group · Healthy men aged 20–65 years who smoked at least 5 cigarettes per day
182 mg4 weeks—
Oral supplementation with all-Rac- and RRR-alpha-tocopherol increases vitamin E levels in human sebum after a latency period of 14-21 days
2004 · RRR-alpha-toc group · Volunteers; age and sex not stated, with no condition reported
400 mg2 weeks—
Oral supplementation with all-Rac- and RRR-alpha-tocopherol increases vitamin E levels in human sebum after a latency period of 14-21 days
2004 · all-rac-alpha-toc group · Volunteers; age and sex not stated, with no condition reported
400 mg2 weeks—
Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E
2006 · TRE 160 mg · Healthy males; age not specified
160 mg60 days—
Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E
2006 · TRE 320 mg · Healthy males; age not specified
320 mg60 days—
Plasma vitamin C and tocotrienols changes in response to dietary supplementation among young male adults
2010 · Combination · young male police recruits
200 mg8 weeks—
Effects of supplementation with tocotrienol-rich fraction on immune response to tetanus toxoid immunization in normal healthy volunteers
2011 · TRF study group · Healthy female volunteers
400 mg60 days—
Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients
2012 · TE supplementation · Adults, including healthy participants and surgical patients; prospective liver-transplantation patients were included
400 mg20 weeks—
Supplementation with tocotrienol-rich fraction alters the plasma levels of Apolipoprotein A-I precursor, Apolipoprotein E precursor, and C-reactive protein precursor from young and old individuals
2013 · TRF · Young adults aged 32 ± 2 years and older adults aged 52 ± 2 years; no condition stated
150 mg26 weeks—
The influence of antioxidant nutrients on platelet function in healthy volunteers
1997 · vitamin E · Healthy volunteers aged 20–50 years
300 mg8 weeks—
Effects of a Novel Nutraceutical Combination (Aquilea Colesterol(®)) on the Lipid Profile and Inflammatory Biomarkers: A Randomized Control Trial
2019 · nutraceutical combination group · Men and women aged 35–75 with primary hypercholesterolemia and low-to-moderate cardiovascular risk
12 mg90 days20
Combination oral antioxidant supplementation reduces blood pressure
1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints.
600 mg8 weeks—
Positive Association of Vitamin E Supplementation with Hemoglobin Levels in Mildly Anemic Healthy Pakistani Adults
2015 · intervention group · Mildly anemic healthy adults in Karachi, Pakistan; ages and sex distribution not stated
400 mg90 days82
Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study
2025 · vitamin E 300 mg group · Adults aged 18–75 with biopsy-proven MASH, without diabetes
300 mg96 weeks58
Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study
2025 · vitamin E 300 mg group · Adults aged 18–75 with biopsy-proven MASH, without diabetes
300 mg96 weeks58
Platelet function in stroke/transient ischemic attack patients treated with tocotrienol
2020 · 400mg TCT · Adults with atherothrombotic, cardio-embolic or cryptogenic TIA or stroke within 6 months, with post-stroke mRS <4 and no indication for anticoagulation
400 mg1 year51
Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: A randomized double-blind active-controlled trial
2022 · α-tocopherol · Patients with non-alcoholic fatty liver disease (NAFLD); age and sex not reported
536 mg48 weeks50
Hepato-Protective Effects of Delta-Tocotrienol and Alpha-Tocopherol in Patients with Non-Alcoholic Fatty Liver Disease: Regulation of Circulating MicroRNA Expression
2022 · αTF group · Men and women aged 20–70 years with non-alcoholic fatty liver disease
536 mg48 weeks50
Effects of delta-tocotrienol supplementation on glycaemic control in individuals with prediabetes: A randomized controlled study
2022 · Group A · Adults aged 18–60 years with prediabetes
300 mg12 weeks40
Reduction of Oxidative Stress in Chronic Kidney Disease Does Not Increase Circulating α-Klotho Concentrations
2016 · anti-oxidant intervention group · Adults aged 20–79 with mild-to-moderate chronic kidney disease (stages 3–4), receiving background ACE-inhibitor or ARB treatment
300 mg26 weeks34
[Efficacy of natural vitamin E on oligospermia and asthenospermia: a prospective multi-centered randomized controlled study of 106 cases]
2012 · Experimental cases with oligospermia · Infertile men with oligospermia
300 mg90 days33
Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial
2012 · Chlorella group · People with non-alcoholic fatty liver disease; age and sex not specified
200 mg90 days33
Effects of meat-based, meat-based with α-tocopherol, and pesco-vegetarian diets on biomarkers associated with colorectal cancer risk: a randomized behavioral intervention trial
2025 · MBD-T · Clinically healthy adults aged 18–50 years
100 mg12 weeks33
Effect of palm-based tocotrienols and tocopherol mixture supplementation on platelet aggregation in subjects with metabolic syndrome: a randomised controlled trial
2017 · PTT mixture intervention · Adults aged 25–60 with metabolic syndrome
400 mg2 weeks31
A Phase IIb Randomized Controlled Trial Investigating the Effects of Tocotrienol-Rich Vitamin E on Diabetic Kidney Disease
2021 · intervention group · Adults aged 18–75 with type 2 diabetes and diabetic kidney disease, including reduced eGFR or microalbuminuria
400 mg1 year31
Combination of vitamin E and clomiphene citrate in treating patients with idiopathic oligoasthenozoospermia: A prospective, randomized trial
2015 · Group A · Men with idiopathic oligoasthenozoospermia
400 mg26 weeks30
Combination of vitamin E and clomiphene citrate in treating patients with idiopathic oligoasthenozoospermia: A prospective, randomized trial
2015 · Group C · Men with idiopathic oligoasthenozoospermia
400 mg26 weeks30
Oxidative stress markers and tissue iron overload after 12-months vitamin E supplementation for children with transfusion-dependent β-thalassemia on different iron chelators: A randomized placebo-controlled trial
2025 · Vitamin E supplementation with desferrioxamine (DFO) · Children with transfusion-dependent β-thalassemia receiving DFO
400 mg1 year30
Oxidative stress markers and tissue iron overload after 12-months vitamin E supplementation for children with transfusion-dependent β-thalassemia on different iron chelators: A randomized placebo-controlled trial
2025 · Vitamin E supplementation with deferiprone (DFP) · Children with transfusion-dependent β-thalassemia receiving DFP
400 mg1 year30
Oxidative stress markers and tissue iron overload after 12-months vitamin E supplementation for children with transfusion-dependent β-thalassemia on different iron chelators: A randomized placebo-controlled trial
2025 · Vitamin E supplementation with deferasirox (DFX) · Children with transfusion-dependent β-thalassemia receiving DFX
400 mg1 year30
Activated and Micronized Zeolite in the Modulation of Cellular Oxidative Stress in Mexican Smokers: A Randomized Clinical Trial
2017 · vitamin E · Mexican smokers without lung diseases
400 mg30 days29
Comparing the effects of vitamin E tocotrienol-rich fraction supplementation and α-tocopherol supplementation on gene expression in healthy older adults
2019 · Tocotrienol-Rich Fraction (TRF) · Healthy adults aged 50–55 years, male and female, without significant clinical disease
150 mg26 weeks24
Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis
2006 · HD treatment group · Adults with end-stage kidney disease receiving hemodialysis; age and sex not specified
300 mg20 weeks19
Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans
2002 · 100 mg/day TRF25 group · Hypercholesterolemic human subjects on the AHA Step-1 diet; age and sex not specified
100 mg5 weeks18
Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis
2006 · PD treatment group · Adults with end-stage kidney disease receiving peritoneal dialysis; age and sex not specified
300 mg20 weeks13
Effect of vitamin E therapy on sexual functions of uremic patients in hemodialysis
1992 · vitamin E · uremic patients on hemodialysis
300 mg8 weeks12
Effects of colon-targeted vitamins on the composition and metabolic activity of the human gut microbiome- a pilot study
2021 · Vitamin E · Healthy adult volunteers; age and sex range not specified
100 mg4 weeks12
Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults
1996 · vitamin E group · healthy adults; age range and sex not reported
400 mg4 weeks10
Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease
2007 · 400 mg/day vitamin E (E400) · Patients with stable COPD
400 mg12 weeks9
Antioxidant effect on urinary excretion of malondialdehyde in non-athletes during aerobic training
2009 · Vitamin E supplemented group · Previously sedentary non-athletes participating in moderate-intensity aerobic training; age and sex not reported
133 mg8 weeks7
Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study
2012 · vitamin E supplementation group · splenectomized patients with beta-thalassemia/hemoglobin E; age and sex not reported
350 mg30 days5
Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients
1999 · vitamin group · Patients with acute anterior uveitis; age and sex not specified
200 mg8 weeks—
Long-term effects of vitamin E, vitamin C, and combined supplementation on urinary 7-hydro-8-oxo-2'-deoxyguanosine, serum cholesterol oxidation products, and oxidation resistance of lipids in nondepleted men
2000 · vitamin C and vitamin E combination · men described as nondepleted; age and condition not stated
182 mg3 years—
Long-term pharmacologic doses of vitamin E only moderately affect the erythrocytes of patients with type 1 diabetes mellitus
2001 · Group S · Patients with type 1 diabetes mellitus; age and sex not reported
504 mg1 year—
Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men
2001 · both vitamins group (CellaVie) · Clinically healthy men with mild hypercholesterolemia and normal vitamin C and E levels
200 mg1 year—
Serum ex vivo lipoprotein oxidizability in patients with ischemic heart disease supplemented with vitamin E
2002 · vitamin E supplemented group · 32 patients with ischemic heart disease and moderate hypercholesterolemia: 16 men and 16 postmenopausal women
400 mg6 weeks—
Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults
2004 · Vitamin E for the first 3-month period · HIV-positive adults with fasting triglycerides ≥2 mmol/L on stable antiretroviral therapy
500 mg90 days—
Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults
2004 · Fenofibrate plus Vitamin E for the additional 3-month period · HIV-positive adults with fasting triglycerides ≥2 mmol/L on stable antiretroviral therapy
500 mg90 days—
Vitamin E improves fibrinolytic activity in patients with coronary spastic angina
2004 · vitamin E group · Patients with coronary spastic angina
400 mg30 days—
The aging/precancerous gastric mucosa: a pilot nutraceutical trial
2004 · vitamin E · Elderly patients with HP-negative atrophic gastritis and intestinal metaplasia
300 mg26 weeks—
Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers
2004 · Slow-release vitamin C with plain-release vitamin E · Male smokers
182 mg4 weeks—
Vitamin C supplementation decreases oxidative DNA damage in mononuclear blood cells of smokers
2004 · Plain-release vitamin C with plain-release vitamin E · Male smokers
182 mg4 weeks—
Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes
2006 · 500 mg alpha-tocopherol/d · Subjects with type 2 diabetes; age and sex not specified
500 mg6 weeks—
Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes
2006 · 500 mg mixed tocopherols/d · Subjects with type 2 diabetes; age and sex not specified
500 mg6 weeks—
Alpha tocopherol supplementation elevates plasma apolipoprotein A1 isoforms in normal healthy subjects
2006 · 134 mg/day AT · healthy adults; sex and age range not specified
134 mg4 weeks—
Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes
2007 · alpha-tocopherol (alphaT) · Patients with type 2 diabetes; age and sex not reported
500 mg6 weeks—
Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes
2007 · mixed tocopherols · Patients with type 2 diabetes; age and sex not reported
500 mg6 weeks—
Reduction of DNA damage in older healthy adults by Tri E Tocotrienol supplementation
2008 · Tri E Tocotrienol · Healthy adults aged 37–78 years
160 mg26 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 4 · Adults aged 60–75 years; elderly participants
200 mg16 weeks—
Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis
2008 · group E (vitamin E) · Adults aged 19–69 with active rheumatoid arthritis
400 mg12 weeks—
Vitamin E supplementation modulates gingival crevicular fluid lipid peroxidation and antioxidant levels in patients with orthodontic tooth movement
2012 · Vitamin E · Patients aged 13–18 years receiving non-extraction orthodontic treatment
300 mg30 days—
Vitamin E supplementation protects erythrocyte membranes from oxidative stress in healthy Chinese middle-aged and elderly people
2012 · VE1 · Healthy adults aged 55–70 years
100 mg120 days—
Vitamin E supplementation protects erythrocyte membranes from oxidative stress in healthy Chinese middle-aged and elderly people
2012 · VE3 · Healthy adults aged 55–70 years
300 mg120 days—
Clinical investigation of the protective effects of palm vitamin E tocotrienols on brain white matter
2014 · mixed tocotrienols group · Volunteers aged 35 years or older with cardiovascular risk factors and MRI-confirmed white matter lesions
400 mg2 years—
Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial
2018 · low TT · Postmenopausal women with osteopenia
430 mg12 weeks—
Vitamin E decreases urine lipid peroxidation products in young healthy human volunteers under normal conditions
1996 · 100 mg of vitamin E · 21 young healthy men
100 mg30 days—
Oxy free radical system in heart failure and therapeutic role of oral vitamin E
1996 · vitamin E supplementation · Adults with heart failure; the abstract says 12 patients were studied prospectively, but separately reports a group of 13 patients with ejection fraction 40%.
400 mg4 weeks—
Effect of 3 months vitamin E supplementation on indices of the cellular and humoral immune response in elderly subjects
1997 · vitamin E group · Adults aged 65 years and over
100 mg90 days—
Erythrocyte membrane fatty acid composition of smokers and non-smokers: effects of vitamin E supplementation
1998 · smokers receiving vitamin E · adult male smokers
280 mg10 weeks—
Erythrocyte membrane fatty acid composition of smokers and non-smokers: effects of vitamin E supplementation
1998 · non-smokers receiving vitamin E · adult male non-smokers
280 mg10 weeks—
Genome-wide association study identifies three common variants associated with serologic response to vitamin E supplementation in men
2012 · α-tocopherol supplementation · Middle-aged male smokers
50 mg3 years2,112
Effect of maternal supplementation with vitamin E on the concentration of α-tocopherol in colostrum
2017 · supplemented group · healthy adult pregnant women who were lactating when colostrum was collected
400 IU1 day60
Interactions between vitamins C and E in human subjects
2000 · Vitamin E supplementation · healthy adults; sex and age range not stated
73.5 mg6 weeks30
The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial
2016 · vitamin E supplements · Patients with diabetic nephropathy; age and sex not stated
1,200 IU12 weeks30
Partial resistance of low density lipoprotein to oxidation in vivo after increased intake of berries
2000 · supplement group · Healthy 60-year-old men
100 mg8 weeks20
Complementary therapy in diabetic patients with chronic complications: a pilot study
2010 · QALAPL group · Patients with diabetes; age and sex not reported
200 mg90 days20
α-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial
2015 · nonfat milk · Healthy adults and adults with metabolic syndrome
15 mg1 day20
α-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial
2015 · reduced-fat milk · Healthy adults and adults with metabolic syndrome
15 mg1 day20
α-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial
2015 · whole milk · Healthy adults and adults with metabolic syndrome
15 mg1 day20
A new formulation of Gamma Delta Tocotrienol has superior bioavailability compared to existing Tocotrienol-Rich Fraction in healthy human subjects
2015 · Naturale3 Gamma Delta Tocotrienol (GDT) · Healthy volunteers aged 22–27 years; 9 men and 3 women enrolled
600 mg1 day12
A new formulation of Gamma Delta Tocotrienol has superior bioavailability compared to existing Tocotrienol-Rich Fraction in healthy human subjects
2015 · Tocovid Suprabio (Tocotrienol-rich fraction; TRF) · Healthy volunteers aged 22–27 years; 9 men and 3 women enrolled
554 mg1 day12
Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin
2004 · group AE · Patients with type 1 diabetes mellitus and high cholesterol; age and sex not reported
750 IU26 weeks11
Effect of an 8-weeks aerobic training program in elderly on oxidative stress and HSP72 expression in leukocytes during antioxidant supplementation
2012 · antioxidant supplemented sedentary group (AS) · Healthy septuagenarians, men and women, mean age 73.4 years; no stated disease or nutrient deficiency.
100 mg8 weeks8
Effect of an 8-weeks aerobic training program in elderly on oxidative stress and HSP72 expression in leukocytes during antioxidant supplementation
2012 · antioxidant supplemented and aerobically trained group (AT) · Healthy septuagenarians, men and women, mean age 75.8 years; no stated disease or nutrient deficiency.
100 mg8 weeks8
Effects of eicosapentaenoic acid supplementation in the treatment of chronic hepatitis C patients
2005 · Control group · Patients with chronic hepatitis C receiving interferon alpha-2b and ribavirin; age and sex not reported
300 mg24 weeks5
Amount of fat in the diet affects bioavailability of lutein esters but not of alpha-carotene, beta-carotene, and vitamin E in humans
2000 · vitamin E group · Volunteers; age, sex, and health status not specified
50 mg2 weeks—
Accumulation and interactions of beta-carotene and alpha-tocopherol in patients with adenomatous polyps
2002 · natural VE · Volunteers with colonic adenomatous polyps; age and sex not reported
400 IU43 days—
Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans
2003 · alpha-tocopherol · adult nonsmokers
400 IU60 days—
Vitamin E supplementation in patients with carotid atherosclerosis: reversal of altered oxidative stress status in plasma but not in plaque
2004 · vitamin E supplementation · patients with severe atherosclerosis who were candidates for carotid endarterectomy
900 mg6 weeks—
Delivery of vitamin E to the skin by a novel liquid skin cleanser: comparison of topical versus oral supplementation
2004 · Dietary vitamin E supplementation group · Panelists; age, sex, and health status not stated
400 IU——
GLV supplements increased plasma beta-carotene, vitamin C, zinc and hemoglobin in young healthy adults
2006 · GLV with vitamin E · Young adults; sex, age range and health condition not reported
100 mg3 weeks—
Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients
2007 · Aqua-E · Patients with cystic fibrosis and documented malabsorption
20 mL1 day—
Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E
2006 · TRE 80 mg · Healthy males; age not specified
80 mg60 days—
Combination treatment with high-dose vitamin C and alpha-tocopherol does not enhance respiratory-tract lining fluid vitamin C levels in asthmatics
2009 · 500 mg tocopherol and 2 g vitamin C · Adults aged 18–50 with allergic moderate-to-severe persistent asthma
500 mg12 weeks—
Effects of vitamin E on plasma lipid status and oxidative stress in Chinese women with metabolic syndrome
2010 · 100 IU /day vitamin E group · Chinese women with metabolic syndrome
100 IU120 days—
Effects of vitamin E on plasma lipid status and oxidative stress in Chinese women with metabolic syndrome
2010 · 200 IU /day vitamin E group · Chinese women with metabolic syndrome
200 IU120 days—
Effects of vitamin E on plasma lipid status and oxidative stress in Chinese women with metabolic syndrome
2010 · 300 IU /day vitamin E group · Chinese women with metabolic syndrome
300 IU120 days—
α-Tocopherol in breast milk of women with preterm delivery after a single postpartum oral dose of vitamin E
2016 · supplemented group · Women who had given birth prematurely and were breastfeeding
400 IU1 day—
Plasma, Prostate and Urine Levels of Tocopherols and Metabolites in Men after Supplementation with a γ-Tocopherol-Rich Vitamin E Mixture
2021 · 1-week supplementation group · Men aged 42–77 with localized prostate cancer undergoing radical prostatectomy
798 mg7 days—
Plasma, Prostate and Urine Levels of Tocopherols and Metabolites in Men after Supplementation with a γ-Tocopherol-Rich Vitamin E Mixture
2021 · 2-week supplementation group · Men aged 42–77 with localized prostate cancer undergoing radical prostatectomy
798 mg2 weeks—
Excretion of alpha-tocopherol into human seminal plasma after oral administration
1995 · 600 mg/day group · Unselected male volunteers
600 mg3 weeks—
Excretion of alpha-tocopherol into human seminal plasma after oral administration
1995 · 800 mg/day group · Unselected male volunteers
800 mg3 weeks—
Excretion of alpha-tocopherol into human seminal plasma after oral administration
1995 · 1200 mg/day group · Unselected male volunteers
1.2 g3 weeks—
Depletion of plasma vitamin C but not of vitamin E in response to cardiac operations
1994 · vitamin E supplementation · Patients undergoing coronary bypass operations
900 mg4 weeks—
Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities
1996 · 15 mg/day alpha-tocopherol group · healthy volunteers; age and sex not stated
15 mg4 weeks—
Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities
1996 · 60 mg/day alpha-tocopherol group · healthy volunteers; age and sex not stated
60 mg4 weeks—
Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group
1998 · subjects receiving 2,000 IU vitamin E orally per day · Patients with early untreated Parkinson's disease
2,000 IU——
Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation
1998 · Group (1) · Healthy volunteers
2 g50 days—
An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients
2016 · Group A (Vitamin E) · Adults aged 18–80 with nonalcoholic fatty liver disease and elevated transaminases, without diabetes or cirrhosis
800 IU52 weeks100
Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial
2016 · α-tocopherol (vitamin E) intervention · Adults with type 1 diabetes, eligible by age and diabetes duration or cardiovascular disease history; Hp genotype groups 1-1, 2-1, and 2-2
400 IU8 weeks87
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
2013 · vitamin E · Adults with histologically defined non-alcoholic steatohepatitis, without diabetes; ages 19–71 in the analysis cohort
800 IU96 weeks84
Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials
2020 · alpha-tocopheryl acetate (ATA), VEAPS · men aged 40 and older without clinical evidence of diabetes or cardiovascular disease
400 IU2 years73
Neutrophil superoxide-anion generating capacity in chronic smoking: effect of long-term alpha-tocopherol therapy
2003 · alpha-tocopherol · adult male chronic smokers
400 IU2 years64
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial
2011 · vitamin E · Children aged 8–17 years with nonalcoholic fatty liver disease and persistently elevated alanine aminotransferase; children with diabetes or cirrhosis were excluded
800 IU96 weeks58
Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin
2021 · vitamin E · Children aged 8–18 years with biopsy-proven NAFLD and persistently elevated ALT
800 IU96 weeks58
Oral alpha-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions
2003 · alpha-tocopherol · Carotid endarterectomy patients with established atherosclerotic lesions; age and sex not specified
500 IU—53
Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials
2020 · ATA alone, ATBC · male smokers aged 50–69 years
50 IU2227 days50
Platelet function in stroke/transient ischemic attack patients treated with tocotrienol
2020 · 800 mg TCT · Adults with atherothrombotic, cardio-embolic or cryptogenic TIA or stroke within 6 months, with post-stroke mRS <4 and no indication for anticoagulation
800 mg1 year50
Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: A randomized double-blind active-controlled trial
2022 · δ-tocotrienol · Patients with non-alcoholic fatty liver disease (NAFLD); age and sex not reported
600 mg48 weeks50
Hepato-Protective Effects of Delta-Tocotrienol and Alpha-Tocopherol in Patients with Non-Alcoholic Fatty Liver Disease: Regulation of Circulating MicroRNA Expression
2022 · δT3 group · Men and women aged 20–70 years with non-alcoholic fatty liver disease
600 mg48 weeks50
New Approach Combination-Dosed Therapy for Nonalcoholic Steatohepatitis Versus Vitamin E: A Randomized Controlled Trial
2025 · group 1 · Patients with nonalcoholic steatohepatitis (NASH); age and sex not stated
800 IU26 weeks45
Vitamin E Improves Serum Paraoxonase-1 Activity and Some Metabolic Factors in Patients with Type 2 Diabetes: No Effects on Nitrite/Nitrate Levels
2016 · vitamin E group · Patients with type 2 diabetes aged 30–60 years
400 IU8 weeks42
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)
1997 · Vitamin E group · Patients aged 5–35 years with recent-onset insulin-dependent diabetes mellitus
15 mg/kg1 year42
Role of δ-tocotrienol and resveratrol supplementation in the regulation of micro RNAs in patients with metabolic syndrome: A randomized controlled trial
2023 · TRM group · Adults with metabolic syndrome; age range and sex not specified
500 mg24 weeks41
Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects
2007 · Vitamin E · Overweight/obese adults with BMI >27 kg/m²; 60 women and 20 men enrolled
800 IU26 weeks39
The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome
2013 · Vitamin E · People with metabolic syndrome
100 IU1 year36
Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study
2021 · PTVE group · Patients with histologically proven non-alcoholic steatohepatitis (NASH)
800 IU1 year36
Measures of cellular oxidative damage following vitamin E supplementation in young patients with transfusion-dependent thalassemia: a double-blind randomized controlled trial
2025 · Vitamin E · Patients aged 10–25 years with transfusion-dependent β- or α-thalassemia requiring at least 7 red blood cell transfusions per year; included splenectomized β-thalassemia, non-splenectomized β-thalassemia, and non-splenectomized α-thalassemia
400 IU26 weeks36
Effects of Delta-tocotrienol Supplementation on Liver Enzymes, Inflammation, Oxidative stress and Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease
2018 · δ-tocotrienol group · Adults aged over 20 years of both sexes with ultrasound-proven fatty liver disease, fatty liver index ≥60, and persistent elevation of alanine transaminase
600 mg12 weeks35
Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial
2020 · δ-tocotrienol group · Patients with nonalcoholic fatty liver disease (age and sex not specified)
600 mg24 weeks35
Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis- A randomized pilot study
2021 · VE group · Patients with histologically proven non-alcoholic steatohepatitis (NASH)
800 IU1 year33
Comparative efficacy of febuxostat and vitamin E in the management of MASLD: Insights from a randomized parallel clinical study
2025 · vitamin E group · Adults with MASLD; age and sex not specified
800 mg24 weeks32
Effect of vitamin E on oxidative stress level in blood, synovial fluid, and synovial tissue in severe knee osteoarthritis: a randomized controlled study
2017 · Group B (vitamin E) · Adults aged 18 years or older with severe knee osteoarthritis scheduled for total knee arthroplasty
400 IU60 days31
[Synergistic antioxidative effect of vitamins E and C on low density lipoproteins from smokers and non-smokers subjects]
2004 · vitamins E and C combination · 20 healthy adult smokers and 10 healthy adult non-smokers
400 mg30 days30
Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity
2015 · VitE arm · Adults with NASH without diabetes
800 IU96 weeks30
The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
2019 · Magnesium plus vitamin E · Women aged 18–40 years with polycystic ovary syndrome
400 mg12 weeks30
Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease
1995 · vitamin E supplementation · Elderly patients (mean age 73.8 years), nondiabetic, moderately obese, with stable effort angina
900 mg120 days30
Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men
2003 · Vitamin E and selenium · Infertile men
400 mg90 days28
Short term effect of atorvastatin and vitamin E on serum levels of C3, a sensitive marker of the risk of myocardial infarction in men
2001 · G5: atorvastatin 10 mg/day + vitamin E 600 IU/day · Men aged 55–64 with persistently elevated C3 levels and total cholesterol of 5.56 mmol/l
600 IU90 days25
The effects of vitamin E on platelet activity in beta-thalassaemia patients
2003 · Vitamin E supplementation · Adults with beta-thalassaemia/haemoglobin E; nine were splenectomized and 16 were non-splenectomized, and all had low plasma alpha-tocopherol levels
525 IU90 days25
The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial
2011 · 800 mg α-tocopherol · Patients with type 2 diabetes mellitus; age and sex not reported
800 mg120 days25
Sesame oil and vitamin E co-administration may improve cardiometabolic risk factors in patients with metabolic syndrome: a randomized clinical trial
2019 · Group A · Adults aged 30–70 years with metabolic syndrome
400 mg8 weeks25
The effect of vitamin E supplementation on biomarkers of endothelial function and inflammation among hemodialysis patients: A double-blinded randomized clinical trial
2020 · intervention group · Hemodialysis patients aged 20–60 years
600 IU10 weeks25
Effects of pomegranate peel extract and vitamin E on the inflammatory status and endothelial function in hemodialysis patients: a randomized controlled clinical trial
2020 · Vit E · Hemodialysis patients; age and sex ranges not reported
400 IU8 weeks25
Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients
1993 · vitamin E · elderly patients with type II diabetes
900 mg90 days25
Effect of vitamin E supplementation on circulating cell adhesion molecules pre- and post-coronary angioplasty
2000 · vitamin E group · Patients undergoing routine percutaneous transluminal coronary angioplasty; age and sex not reported
800 IU30 days23
The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial
2019 · ALA · Obese patients with non-alcoholic fatty liver disease; age and sex not specified
400 mg12 weeks23
Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study
1997 · Vitamin E treatment phase · Adults with hepatitis C refractory to alpha-interferon therapy; age and sex not reported
800 IU12 weeks23
Effects of postmenopausal hormone replacement and alpha-tocopherol on the lipid profiles and antioxidant status
1997 · third group (n = 22) · Postmenopausal women
600 mg26 weeks22
Increased antioxidant capacity in healthy volunteers taking a mixture of oral antioxidants versus vitamin C or E supplementation
2007 · vitamin E · Healthy adults aged 19–23 years
400 IU7 days21
Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation
1999 · vitamin E group · Hyperlipidaemic patients; age and sex not reported
100 IU—20
Prolonged, low dose alpha-tocopherol therapy counteracts intercellular cell adhesion molecule-1 activation
2002 · alpha-tocopherol E · Healthy male volunteers, mean age 41.6 years
50 IU20 weeks20
Complementary therapy in diabetic patients with chronic complications: a pilot study
2010 · QALA group · Patients with diabetes; age and sex not reported
200 mg90 days20
Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis
2011 · Group 2 · Adults aged 18–60 with end-stage renal disease receiving hemodialysis
400 IU3 weeks20
[Diabetes mellitus--a free radical-associated disease. Results of adjuvant antioxidant supplementation]
1993 · D-alpha-tocopherol group · Patients with diabetes mellitus and long-term diabetic late syndrome; age and sex not reported
1,200 IU90 days20
Effects of vitamin E on chronic hepatitis C genotype 3: a randomized, double-blind, placebo-controlled study
2014 · vitamin E group · Patients with HCV genotype 3 infection who were unable to receive or tolerate standard therapy, or did not respond to it; age and sex not reported.
800 IU12 weeks19
Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial
2016 · Control group · Adults aged 20–50 years with obesity (BMI 30–40 kg/m²) and non-alcoholic fatty liver disease, taking vitamin E as routine treatment
400 IU8 weeks19
The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes
2004 · group V · Adults with type 2 diabetes; age and sex not reported
150 mg90 days18
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype
2008 · vitamin E · Adults with type 2 diabetes, Hp 2-2 genotype, and no antioxidant therapy at baseline
400 IU60 days18
Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults
2002 · RRR-alpha-tocopherol · Healthy adults
400 IU2 weeks17
Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial
2001 · vitamin E group · Patients with chronic hepatitis B; age and sex not specified
600 mg90 days15
Effect of tocopherol on platelet aggregation in non-insulin-dependent diabetes mellitus: ex vivo and in vitro studies
1992 · tocopherol · People with non-insulin-dependent diabetes mellitus; age and sex not stated
600 mg6 weeks15
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis
2006 · UDCA/Vit E · Patients with biopsy-proven nonalcoholic steatohepatitis and elevated aminotransferase levels, drinking less than 40 g alcohol per week
800 IU2 years15
Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial
2024 · TRF treatment group · Children aged 10–18 years who were overweight or obese and had NAFLD
50 mg26 weeks15
Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial
2024 · TRF treatment group · Children aged 10–18 years who were overweight or obese and had NAFLD
50 mg26 weeks15
Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients
1993 · Vitamin E-supplemented non-insulin-dependent diabetic patients · Non-insulin-dependent diabetic patients
900 mg120 days15
Vitamin E improves arterial compliance in middle-aged men and women
1999 · vitamin E group · middle-aged men and women; no condition stated
400 IU8 weeks14
Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin
2006 · vitamin group · Patients with chronic hepatitis C receiving interferon-alpha-2b and ribavirin combination therapy; age and sex not reported
500 mg8 weeks14
Effect of alpha-tocopherol on the metabolic control and oxidative stress in female type 2 diabetics
2005 · alpha-tocopherol group · Women aged 40–70 with type 2 diabetes
800 IU6 weeks13
Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children
2000 · Vitamin E · Children with type 1 diabetes; ages and sex not stated
100 IU90 days12
Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein
1992 · alpha-tocopherol group · male subjects; no age range or condition stated
800 IU12 weeks12
Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin
2007 · control group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy
300 mg48 weeks12
Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients
1998 · vitamin E · adults with type 1 diabetes
100 IU90 days12
Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners
2004 · antioxidants (AO) · Ultramarathon runners participating in a 50 km race; age and sex distribution not reported
300 mg6 weeks11
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
2004 · vitamin E alone · Nondiabetic, noncirrhotic patients with nonalcoholic steatohepatitis (NASH)
400 IU—10
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
2004 · vitamin E and pioglitazone combination therapy · Nondiabetic, noncirrhotic patients with nonalcoholic steatohepatitis (NASH)
400 IU—10
Effects of high-dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus
2007 · vitamin E group · Caucasian young adults with childhood-onset type 1 diabetes mellitus and persistent microalbuminuria; mean age 18.87 years; 7 male and 3 female overall
1.2 g26 weeks10
Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test--a randomised controlled trial
2007 · α-tocopherol group · Caucasian men aged 50–65 with type 2 diabetes
1,200 IU4 weeks10
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications?
1991 · 1200 mg vitamin E group · Insulin-requiring diabetic patients; age and sex not stated
1.2 g60 days10
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications?
1991 · 600 mg vitamin E group · Insulin-requiring diabetic patients; age and sex not stated
600 mg60 days10
Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients
1993 · Vitamin E-supplemented healthy control subjects · Healthy control subjects
900 mg120 days10
Supplementation with vitamins C and E enhances cytokine production by peripheral blood mononuclear cells in healthy adults
1996 · vitamins C and E group · healthy adults; age range and sex not reported
400 mg4 weeks10
An evaluation of antiretroviral therapy associated with alpha-tocopherol supplementation in HIV-infected patients
2002 · alpha-tocopherol-supplemented group · HIV-seropositive patients
800 mg60 days9
The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study
1995 · 60 IU/d alpha-tocopherol group · Human subjects; age, sex, and health status not reported
60 IU8 weeks8
The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study
1995 · 200 IU/d alpha-tocopherol group · Human subjects; age, sex, and health status not reported
200 IU8 weeks8
The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study
1995 · 400 IU/d alpha-tocopherol group · Human subjects; age, sex, and health status not reported
400 IU8 weeks8
The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study
1995 · 800 IU/d alpha-tocopherol group · Human subjects; age, sex, and health status not reported
800 IU8 weeks8
The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study
1995 · 1200 IU/d alpha-tocopherol group · Human subjects; age, sex, and health status not reported
1,200 IU8 weeks8
Total radical-trapping antioxidant potential (TRAP) of plasma: effects of supplementation of young healthy volunteers with large doses of alpha-tocopherol and ascorbic acid
1993 · Group 3, alpha-tocopherol · Young healthy adults; age range and sex not reported
1 g4 weeks8
Increased serum and low-density-lipoprotein antioxidant potential after antioxidant supplementation in endurance athletes
1997 · antioxidant trial · Eight endurance athletes
294 mg4 weeks8
Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E
1991 · TPGS treatment · Six paediatric liver-transplant recipients and one young adult with severe hepatobiliary graft-versus-host disease after bone-marrow transplantation
25 mg/kg60 days7
Vitamin E supplementation and hepatic drug metabolism in humans
2009 · RRR-alpha-TOH group · 12 healthy subjects, with 6 assigned to this arm; age and sex not stated
750 IU3 weeks6
Effects of lovastatin therapy on susceptibility of LDL to oxidation during alpha-tocopherol supplementation
1999 · alpha-tocopherol with lovastatin · Men with verified coronary heart disease and hypercholesterolemia
450 IU6 weeks—
Effects of lovastatin therapy on susceptibility of LDL to oxidation during alpha-tocopherol supplementation
1999 · alpha-tocopherol with dummy tablets · Men with verified coronary heart disease and hypercholesterolemia
450 IU6 weeks—
Effects of vitamin E and glutathione on glucose metabolism: role of magnesium
1999 · vitamin E · Hypertensive patients; age and sex not specified
600 mg4 weeks—
Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes
1999 · Vitamin E · Adults with type 1 diabetes and age- and sex-matched control subjects
400 IU8 weeks—
Alpha-tocopherol dietary supplement decreases titers of antibody against 5-hydroxymethyl-2'-deoxyuridine (HMdU)
1999 · 15 mg/day alpha-tocopherol group · Eligible subjects in a phase II chemoprevention trial; age, sex, and condition are not specified
15 mg4 weeks—
Alpha-tocopherol dietary supplement decreases titers of antibody against 5-hydroxymethyl-2'-deoxyuridine (HMdU)
1999 · 60 mg/day alpha-tocopherol group · Eligible subjects in a phase II chemoprevention trial; age, sex, and condition are not specified
60 mg4 weeks—
The effect of vitamin E and vitamin C supplementation on LDL oxidizability and neutrophil respiratory burst in young smokers
2000 · vitamin E · young smokers with a history of less than 5 pack-years
400 IU8 weeks—
Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study
2000 · d-alpha-tocopherol group · Subjects with mild hypercholesterolemia undergoing statin treatment
700 mg90 days—
Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers
2001 · alpha-tocopherol · Adult male normolipidemic chronic smokers
400 IU2 years—
Vitamin E supplementation reduces plasma vascular cell adhesion molecule-1 and von Willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients
2002 · 400 IU/day vitamin E · Adults with hypercholesterolemia; age range and sex not specified
400 IU8 weeks—
Vitamin E supplementation reduces plasma vascular cell adhesion molecule-1 and von Willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients
2002 · 800 IU/day vitamin E · Adults with hypercholesterolemia; age range and sex not specified
800 IU8 weeks—
Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial
2002 · vitamin E alone · nonsmokers
400 IU60 days—
Effect of vitamin E and eccentric exercise on selected biomarkers of oxidative stress in young and elderly men
2003 · Vitamin E, young men · Healthy men aged 26.4 ± 3.3 years
1,000 IU12 weeks—
Effect of vitamin E and eccentric exercise on selected biomarkers of oxidative stress in young and elderly men
2003 · Vitamin E, older men · Healthy men aged 71.1 ± 4.0 years
1,000 IU12 weeks—
Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study
2003 · Vitamin E treatment group · Children with biopsy-proven IgA nephropathy, weighing 30 kg as described in the abstract
400 IU2 years—
Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments
2003 · Vitamin E supplementation in simvastatin-treated patients · Patients with hypercholesterolemia receiving simvastatin
400 IU26 weeks—
Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments
2003 · Vitamin E supplementation in bezafibrate-treated patients · Patients with hypercholesterolemia receiving bezafibrate
400 IU26 weeks—
Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes
2004 · Vitamin E group · Patients with acute coronary syndromes; smoker subgroup results were reported
400 IU26 weeks—
Randomized, placebo-controlled pilot trial of the effects of alpha-tocopherol supplementation on levels of autoantibodies against 5-hydroxymethyl-2-deoxyuridine in melanoma patients
2004 · alpha-tocopherol treatment group · Melanoma outpatients; age and sex not specified
1 g90 days—
Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status
2004 · Vitamin E supplementation, study A · Men and women with rheumatoid arthritis, not taking oral anticoagulants
1,000 IU12 weeks—
Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status
2004 · Vitamin E supplementation, study B · Healthy men, not taking oral anticoagulants
1,000 IU12 weeks—
Effect of vitamin E on carotid artery elasticity and baroreflex gain in young, healthy adults
2004 · active treatment group · young, healthy adults
700 IU30 days—
Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial
2005 · group 2 · Clinically stable, non-diabetic adults on haemodialysis or peritoneal dialysis without manifest cardiovascular disease
800 IU12 weeks—
Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial
2005 · group 3 · Clinically stable, non-diabetic adults on haemodialysis or peritoneal dialysis without manifest cardiovascular disease
800 IU12 weeks—
Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease
2007 · RRR-α-tocopherol group · Adults aged 40–70 with stable coronary artery disease, receiving lipid-lowering medication
1,200 IU2 years—
Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome
2008 · AT (RRR) alone · Adults recruited from the community with at least three features of metabolic syndrome
800 mg6 weeks—
Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome
2008 · GT · Adults recruited from the community with at least three features of metabolic syndrome
800 mg6 weeks—
The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level
2008 · vitamin E capsule and placebo tablet · Adults aged 18 years or older; healthy nonsmokers without the listed excluded diseases
800 IU60 days—
Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease
2009 · Vitamin E (with or without orange and blackcurrant juice) · Patients with peripheral arterial disease; age and sex not specified
15 mg4 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 5 · Adults aged 60–75 years; elderly participants
5 mg16 weeks—
Vitamin C treatment reduces elevated C-reactive protein
2009 · Vitamin E group · Healthy nonsmokers; adults, mean age 44 years; not restricted to elevated CRP
800 IU60 days—
Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritis
2008 · group CE (CLAs and vitamin E) · Adults aged 19–69 with active rheumatoid arthritis
400 mg12 weeks—
Investigation of the effects of oral administration of vitamin E and beta-carotene on the chemiluminescence responses and the frequency of sister chromatid exchanges in circulating leukocytes from cigarette smokers
1990 · Group 1 · Asymptomatic cigarette smokers; age and sex not specified
900 IU6 weeks—
Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure
2013 · vitamin E supplementation · Adults with end-stage renal failure receiving chronic hemodialysis; age range and sex not stated
800 IU12 weeks—
α-Tocopherol supplementation reduces biomarkers of oxidative stress in children with Down syndrome: a randomized controlled trial
2014 · α-tocopherol · Children aged 7–15 years, both sexes, with Down syndrome
400 IU120 days—
Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress
2016 · vitamin E · men aged 55 years or older (50 or older for African Americans) who were current smokers without COPD
400 IU3 years—
Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: a 12-week randomized double-blinded placebo-controlled trial
2018 · high TT · Postmenopausal women with osteopenia
860 mg12 weeks—
Effects of High-dose Vitamin E Supplementation on Markers of Cardiometabolic Risk and Oxidative Stress in Patients with Diabetic Nephropathy: a Randomized Double-blinded Controlled Trial
2018 · vitamin E supplement group · Patients with diabetic nephropathy
800 IU12 weeks—
Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment
2018 · vitamin E · Patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD)
400 IU52 weeks—
Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment
2018 · spironolactone plus vitamin E · Patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD)
400 IU52 weeks—
Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial
2019 · vitamin E 400 IU/day · Adults aged 18–65 with nonalcoholic fatty liver disease
400 IU90 days—
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
2019 · vitamin E · Patients with type 2 diabetes and biopsy-proven nonalcoholic steatohepatitis
800 IU548 days—
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
2019 · vitamin E plus pioglitazone · Patients with type 2 diabetes and biopsy-proven nonalcoholic steatohepatitis
800 IU548 days—
Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function
2021 · vitamin E treatment · Overweight subjects with elevated alanine aminotransferase (ALT)
800 IU8 weeks—
Derepression of glomerular filtration, renal blood flow and antioxidant defence in patients with type 2 diabetes at high-risk of cardiorenal disease
2020 · vitamin E · Adults with type 2 diabetes and hypertension and/or microalbuminuria, eGFR >45 mL/min/1.73 m²; non-Caucasian or Caucasian
400 IU1 year—
A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients
2021 · group 1 (Vitamin E) · Egyptian patients with non-alcoholic steatohepatitis (age and sex not specified)
800 mg90 days—
Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM
1995 · vitamin E · men aged 50–70 with non-insulin-dependent diabetes mellitus (NIDDM) and HbA1c 6–10%
1,600 IU10 weeks—
Cerebrospinal fluid homovanillic acid in the DATATOP study on Parkinson's disease. Parkinson Study Group
1995 · selegiline-placebo and active tocopherol · Adults with early, mild, untreated Parkinson's disease
2,000 IU——
Cerebrospinal fluid homovanillic acid in the DATATOP study on Parkinson's disease. Parkinson Study Group
1995 · active selegiline hydrochloride and active tocopherol · Adults with early, mild, untreated Parkinson's disease
2,000 IU——
The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans
1994 · vitamin E · Hypercholesterolaemic patients already receiving simvastatin
400 IU8 weeks—
The beneficial effect of dietary antioxidant supplementation on platelet aggregation and cyclosporine treatment in heart transplant recipients
1994 · vitamin E group · Heart transplant recipients; age and sex not reported
500 IU60 days—
Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation
1993 · alpha-tocopherol only · adult male subjects; age and health condition not specified
800 IU90 days—
Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation
1993 · RRR-alpha-tocopherol group · Men and women; ages and health status not specified
1.6 g8 weeks—
Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation
1993 · Racemic alpha-tocopherol group · Men and women; ages and health status not specified
1.6 g8 weeks—
RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus
1996 · RRR-alpha-tocopherol-supplemented group · People with insulin-dependent or non-insulin-dependent diabetes mellitus, without evidence of vascular disease
1.63 g8 weeks—
What dose of vitamin E is required to reduce susceptibility of LDL to oxidation?
1996 · 500 IU/day vitamin E · Healthy volunteers
500 IU6 weeks—
What dose of vitamin E is required to reduce susceptibility of LDL to oxidation?
1996 · 1000 IU/day vitamin E · Healthy volunteers
1,000 IU6 weeks—
What dose of vitamin E is required to reduce susceptibility of LDL to oxidation?
1996 · 1500 IU/day vitamin E · Healthy volunteers
1,500 IU6 weeks—
Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans
1997 · Olive oil with vitamin E · Healthy men; age not stated
900 IU6 weeks—
Vitamin E supplementation in elderly lowers the oxidation rate of linoleic acid in LDL
1997 · vitamin E group · Apparently healthy Dutch adults aged 67–85 years
100 IU90 days—
Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
1997 · RRR-AT 100 IU/d · Healthy people; age and sex not specified
100 IU8 weeks—
Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
1997 · RRR-AT 200 IU/d · Healthy people; age and sex not specified
200 IU8 weeks—
Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
1997 · RRR-AT 400 IU/d · Healthy people; age and sex not specified
400 IU8 weeks—
Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
1997 · RRR-AT 800 IU/d · Healthy people; age and sex not specified
800 IU8 weeks—
Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
1997 · all-rac-AT 100 IU/d · Healthy people; age and sex not specified
100 IU8 weeks—
Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
1997 · all-rac-AT 200 IU/d · Healthy people; age and sex not specified
200 IU8 weeks—
Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
1997 · all-rac-AT 400 IU/d · Healthy people; age and sex not specified
400 IU8 weeks—
Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
1997 · all-rac-AT 800 IU/d · Healthy people; age and sex not specified
800 IU8 weeks—
Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance
1997 · vitamin E group · Normal volunteers and patients with ischemic heart disease; ages and sex not reported
600 mg6 days—
Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo
1998 · vitamin E · Participants in the second study; sex, age range, and health status not reported
1,000 IU2 weeks—
Vitamin E levels during early iron supplementation in preterm infants
2009 · 2-week group · Preterm infants assigned to start iron supplementation at 2 weeks of age
25 IU6 weeks62
Vitamin E levels during early iron supplementation in preterm infants
2009 · 4-week group · Preterm infants assigned to start iron supplementation at 4 weeks of age
25 IU4 weeks54
Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes
2000 · nonsmokers receiving vitamin cocktail · Male nonsmokers selected for low fruit and vegetable intake
31 mg90 days38
Ascorbate is depleted by smoking and repleted by moderate supplementation: a study in male smokers and nonsmokers with matched dietary antioxidant intakes
2000 · smokers receiving vitamin cocktail · Male smokers selected for low fruit and vegetable intake
31 mg90 days37
Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke
2005 · Treatment group · Acute ischaemic stroke patients treated within 12 hours of symptom onset
800 IU2 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · Antioxidant vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
800 IU2 weeks24
Effect of combined coenzyme Q10 and d-alpha-tocopheryl acetate supplementation on exercise-induced lipid peroxidation and muscular damage: a placebo-controlled double-blind study in marathon runners
1998 · antioxidant cocktail · Moderately trained male marathon runners
13.5 mg3 weeks18
Supplementation with antioxidants prior to bone marrow transplantation
1997 · BMT(+) · Bone marrow transplant patients receiving conditioning therapy
825 mg3 weeks16
Effect of Vitamin E With Therapeutic Iron Supplementation on Iron Repletion and Gut Microbiome in US Iron Deficient Infants and Toddlers
2016 · iron + vitamin E (Fe + E group) · Infants and toddlers aged 9–24 months with iron deficiency or iron deficiency anemia
18 mg8 weeks15
Combined effect of antioxidant supplementation and resistance training on oxidative stress markers, muscle and body composition in an elderly population
2011 · AS (vitamin C and E supplementation) · Healthy sedentary adults aged 59–73 years, men and women
400 IU26 weeks14
Combined effect of antioxidant supplementation and resistance training on oxidative stress markers, muscle and body composition in an elderly population
2011 · AS + RT (vitamin C and E supplementation combined with resistance training) · Healthy sedentary adults aged 59–73 years, men and women
400 IU26 weeks14
The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C
2009 · low dose vitamins · Adults with well-controlled, non-insulin-requiring type 2 diabetes; men and women, mean age 53 years
200 IU2 weeks12
The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C
2009 · medium dose vitamins · Adults with well-controlled, non-insulin-requiring type 2 diabetes; men and women, mean age 53 years
400 IU2 weeks12
The response of gamma vitamin E to varying dosages of alpha vitamin E plus vitamin C
2009 · high dose vitamins · Adults with well-controlled, non-insulin-requiring type 2 diabetes; men and women, mean age 53 years
800 IU2 weeks12
Noncompetitive plasma biokinetics of deuterium-labeled natural and synthetic alpha-tocopherol in healthy men with an apoE4 genotype
2005 · RRR-alpha-tocopheryl acetate treatment · Healthy men with the apoE4 genotype
400 mg4 weeks10
Noncompetitive plasma biokinetics of deuterium-labeled natural and synthetic alpha-tocopherol in healthy men with an apoE4 genotype
2005 · all-rac-alpha-tocopheryl acetate treatment · Healthy men with the apoE4 genotype
400 mg4 weeks10
Effect of the main dietary antioxidants (carotenoids, gamma-tocopherol, polyphenols, and vitamin C) on alpha-tocopherol absorption
2007 · Meal containing 18 mg lutein · Healthy men; age not reported
24 mg1 day8
Effect of the main dietary antioxidants (carotenoids, gamma-tocopherol, polyphenols, and vitamin C) on alpha-tocopherol absorption
2007 · Meal containing 36 mg lutein · Healthy men; age not reported
24 mg1 day8
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · evening primrose oil (EPO) · Healthy subjects; age and sex not specified
205 mg12 weeks—
Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study
2000 · Q10 and d-alpha-tocopherol group · Subjects with mild hypercholesterolemia undergoing statin treatment
700 mg90 days—
Accumulation and interactions of beta-carotene and alpha-tocopherol in patients with adenomatous polyps
2002 · combination BC/VE · Volunteers with colonic adenomatous polyps; age and sex not reported
400 IU43 days—
Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function
2003 · group A [low dose of supplement] · Patients with cystic fibrosis; age and sex not specified
10 mg8 weeks—
Effects of maternal antioxidant supplementation on maternal and fetal antioxidant levels: a randomized, double-blind study
2003 · Supplemented women · Pregnant women starting supplementation at 35 weeks' gestation
400 IU——
Differential response of plasma and immune cell's vitamin E levels to physical activity and antioxidant vitamin supplementation
2005 · supplemented group · trained male amateur runners aged 32–36 years who participated in a half-marathon
50 mg30 days—
Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention
2014 · LXS group, ages 5.0 to 11.9 years · Children aged 5.0–11.9 years with cystic fibrosis, pancreatic insufficiency, and mild to moderate lung disease
9.6 mg1 year—
Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention
2014 · LXS group, ages 12.0 to 17.9 years · Children and adolescents aged 12.0–17.9 years with cystic fibrosis, pancreatic insufficiency, and mild to moderate lung disease
14.4 mg1 year—
Antioxidant vitamin supplementation prevents oxidative stress but does not enhance performance in young football athletes
2019 · antioxidant-supplemented · Young football athletes; age and sex not specified
400 IU15 days—
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
1996 · Treatment 1 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified
600 mg7 days—
Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network
1996 · V (vitamins) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized
15 mg26 weeks—
Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters
1997 · vitamin group · Hospitalized adults older than 65 years; baseline vitamin C deficiency was common
15 mg2 years—
Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX
1997 · vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care
15 mg1 year—
The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes
2004 · group MV · Adults with type 2 diabetes; age and sex not reported
150 mg90 days17
Antenatal Multiple Micronutrient Supplementation Compared to Iron-Folic Acid Affects Micronutrient Status but Does Not Eliminate Deficiencies in a Randomized Controlled Trial Among Pregnant Women of Rural Bangladesh
2019 · MM · Pregnant women aged 12–45 years in rural Bangladesh
15 mg165 days749
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication.
40 mg24 weeks501
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2.
40 mg24 weeks201
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
15 mg—176
Multiple Micronutrient Powder Reduces Vitamin E Deficiency in Brazilian Children: A Pragmatic, Controlled Clinical Trial
2019 · intervention group · Children aged 6–9 months at the start of the study, male or female, attending primary health care centers in Goiânia, Brazil
5 mg90 days107
Proliferative changes in the bronchial epithelium of former smokers treated with retinoids
2007 · 13-cis-RA and α-tocopherol group · Former smokers with a history of at least 20 pack-years who had stopped smoking at least 12 months before study entry; adult age range not stated
1,200 IU90 days77
Comparison of L-Carnitine vs. Coq10 and Vitamin E for idiopathic male infertility: a randomized controlled trial
2022 · control group · men with asthenozoospermia and teratozoospermia
300 mg90 days70
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
2019 · treated · Adults aged 18–80 with histologically diagnosed nonalcoholic fatty liver disease (NAFLD)
30 mg26 weeks60
Trace element supplementation in hemodialysis patients: a randomized controlled trial
2015 · medium dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease
250 IU180 days52
[Effects of vitamins E, C and beta-carotene on DNA damage]
1999 · trial group · Healthy men aged 50–59 years
280 mg20 weeks50
Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease
2022 · active group · People with mild-moderate Alzheimer's disease; age and sex not reported
15 mg1 year50
Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy
1996 · 100 mg alpha-tocopheryl acetate daily phase · Postmenopausal women, equally divided between those using and not using hormone-replacement therapy
100 mg5 weeks48
Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy
1996 · 200 mg alpha-tocopheryl acetate daily phase · Postmenopausal women, equally divided between those using and not using hormone-replacement therapy
200 mg5 weeks48
Effects of interaction of RRR-alpha-tocopheryl acetate and fish oil on low-density-lipoprotein oxidation in postmenopausal women with and without hormone-replacement therapy
1996 · 400 mg alpha-tocopheryl acetate daily phase · Postmenopausal women, equally divided between those using and not using hormone-replacement therapy
400 mg5 weeks48
Trace element supplementation in hemodialysis patients: a randomized controlled trial
2015 · low dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease
250 IU180 days47
Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls
2005 · type 2 diabetes group · Adults with early-stage, untreated type 2 diabetes
300 g15 days46
Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls
2005 · impaired glucose tolerance group · Adults with impaired glucose tolerance
300 g15 days46
Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls
2005 · healthy control group · Healthy adults
300 g15 days46
Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial
2005 · vitamin E and vitamin C group · Patients with asymptomatic or mildly symptomatic moderate chronic degenerative aortic stenosis, with or without concomitant coronary artery disease; age and sex not reported
400 IU26 weeks41
Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults
2003 · spread A · healthy adults
43 mg11 weeks35
Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults
2003 · spread B · healthy adults
111 mg11 weeks35
The effect of selenium and vitamin E supplementation on anti-Mullerian hormone and antral follicle count in infertile women with occult premature ovarian insufficiency: A randomized controlled clinical trial
2021 · treatment group · Infertile women with occult premature ovarian insufficiency
400 IU90 days35
Circulating levels of reactive oxygen species in patients with nonproliferative diabetic retinopathy and the influence of antioxidant supplementation: 6-month follow-up
2015 · Group A (antioxidant dietary supplementation) · Adults aged 40–79 with type 2 diabetes and mild or moderate nonproliferative diabetic retinopathy
30 mg26 weeks34
The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome
2017 · omega-3 fatty acids and vitamin E · Women aged 18–40 years with polycystic ovary syndrome diagnosed according to the Rotterdam criteria
400 IU12 weeks34
The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
2017 · omega-3 fatty acids and vitamin E co-supplementation · Women aged 18–40 years with polycystic ovary syndrome
400 IU12 weeks34
Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese/overweight women with polycystic ovary syndrome
2020 · omega-3 plus vitamin E group · Women with polycystic ovary syndrome and BMI >25 who were overweight or obese
400 IU8 weeks32
Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients
2001 · combined vitamin C and E treatment · Adults with type 2 diabetes and persistent micro/macroalbuminuria (urinary albumin excretion rate 30–300 mg/24 h)
680 IU4 weeks30
A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes
2016 · omega-3 fatty acids plus vitamin E group · Women with gestational diabetes who were not taking oral hypoglycemic agents
400 IU6 weeks30
A Randomized Controlled Clinical Trial Investigating the Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Biomarkers of Oxidative Stress, Inflammation and Pregnancy Outcomes in Gestational Diabetes
2017 · omega-3 fatty acids plus vitamin E · Women with gestational diabetes who were not taking oral hypoglycemic agents
400 IU6 weeks30
The effects of magnesium and vitamin E co-supplementation on parameters of glucose homeostasis and lipid profiles in patients with gestational diabetes
2018 · magnesium plus vitamin E group · Women aged 18–40 with gestational diabetes, non-diabetic before pregnancy
400 IU6 weeks30
The Effect of Combined Vitamin C and Vitamin E Supplementation on Oxidative Stress Markers in Women with Endometriosis: A Randomized, Triple-Blind Placebo-Controlled Clinical Trial
2021 · Group A · Women aged 15–45 with pelvic pain and laparoscopically confirmed stage 1–3 endometriosis
800 IU8 weeks30
Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment
2005 · vitamin E plus vitamin C combination · Patients with histologically proven fatty liver disease and chronically elevated alanine aminotransferase despite a three-month reducing diet; age and sex distribution not stated
600 IU26 weeks28
Metabolic Response to Omega-3 Fatty Acids and Vitamin E Co-Supplementation in Patients with Fibrocystic Breast Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
2017 · omega-3 fatty acids plus vitamin E · Patients with fibrocystic breast disease
400 mg12 weeks28
The effect of zinc and vitamin E cosupplementation on metabolic status and its related gene expression in patients with gestational diabetes
2019 · Zinc gluconate plus vitamin E · Women aged 18–40 with gestational diabetes mellitus
400 IU6 weeks27
High 15-F2t-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy
2015 · supplemented group · Adults aged 20 years or older with a previous history of nonmelanoma skin cancer treated by surgery
400 IU60 days26
Effect of Vitamin E Supplement on Bone Turnover Markers in Postmenopausal Osteopenic Women: A Double-Blind, Randomized, Placebo-Controlled Trial
2021 · study group · Postmenopausal women over 45 with osteopenia
400 IU12 weeks26
Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects
1998 · vitamin group · HIV-positive patients; age and sex not specified
800 IU90 days26
The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial
2011 · 800 mg α-tocopherol + 600 mg LA · Patients with type 2 diabetes mellitus; age and sex not reported
800 mg120 days25
Effects of pomegranate peel extract and vitamin E on the inflammatory status and endothelial function in hemodialysis patients: a randomized controlled clinical trial
2020 · PPE + Vit E · Hemodialysis patients; age and sex ranges not reported
400 IU8 weeks25
Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial
2021 · Liposomal group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis
200 IU90 days25
Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial
2021 · MCT group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis
200 IU90 days25
Soy isoflavones improve bone metabolism in postmenopausal Japanese women
2004 · V · Women; a subgroup of the study participants was postmenopausal
5 mg4 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
800 IU2 weeks24
Antioxidants restore protoporphyrinogen oxidase in variegate porphyria patients
2013 · vitamins E and C treatment phase · 12 women with variegate porphyria and 12 control women
50 mg26 weeks24
Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes
2003 · Fish oil group · Adults with type 2 diabetes
53.6 mg8 weeks23
[Efficacy of natural vitamin E on oligospermia and asthenospermia: a prospective multi-centered randomized controlled study of 106 cases]
2012 · Experimental cases with asthenospermia · Infertile men with asthenospermia
300 mg90 days22
Antioxidant vitamins and low-density-lipoprotein oxidation
1993 · antioxidant supplementation · Adults; ages and health conditions not stated
200 mg26 weeks22
Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes
2003 · Corn oil group · Adults with type 2 diabetes
53.6 mg8 weeks21
[A randomized single-blind trial of the effects of vitamins C and E in familial hypercholesterolemia]
2006 · vitamin therapy group · Girls and boys aged 2–18 years with heterozygous familial hypercholesterolemia and LDL-cholesterol above 160 mg/dl
400 IU1 year21
Prospective analysis of serum carotenoids, vitamin A, and tocopherols in adults with short bowel syndrome undergoing intestinal rehabilitation
2009 · All subjects (shared oral multivitamin-mineral supplementation) · Adults with severe short bowel syndrome dependent on parenteral nutrition
90 mg11 weeks21
Boosting Antioxidant Defense: The Effect of Astaxantin on Superoxidase Dismutase and Malondialdehyde Reduction in Patients with Head and Neck Cancer Receiving Cisplatin Chemotherapy
2024 · Vitamin C and E group · Patients aged over 11 and under 80 with stage II–IV head and neck cancer receiving cisplatin chemotherapy; males and females
250 IU3 weeks21
Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial
1992 · active treatment · Patients with recurrent non-gallstone pancreatitis
270 IU10 weeks20
Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis
2011 · Group 3 · Adults aged 18–60 with end-stage renal disease receiving hemodialysis
400 IU3 weeks20
Beneficial effects of omega-3 and vitamin E coadministration on gene expression of SIRT1 and PGC1α and serum antioxidant enzymes in patients with coronary artery disease
2016 · Group 2 (OE) · Male patients with coronary artery disease; age range not reported
400 IU60 days20
Redox-regulation of haemostasis in hypoxic exercising humans: a randomised double-blind placebo-controlled antioxidant study
2018 · antioxidant group · Healthy males
900 IU8 weeks20
The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial
2019 · omega-3 fatty acids plus vitamin E · Patients with Parkinson's disease; age range and sex not reported
400 IU12 weeks20
Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial
2002 · vitamin group · cardiac transplant recipients 0–2 years after transplantation
800 IU1 year19
Influence of vitamin C and E supplementation on oxidative stress induced by hyperbaric oxygen in healthy men
2006 · Daily vitamin C and vitamin E supplementation · Healthy men
272 IU4 weeks19
Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial
2016 · Intervention group · Adults aged 20–50 years with obesity (BMI 30–40 kg/m²) and non-alcoholic fatty liver disease, taking vitamin E as routine treatment
400 IU8 weeks19
Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes
2005 · group V · Patients with type 2 diabetes; age range and sex not specified
100 IU90 days18
Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress
1999 · LA alone for 2 months, followed by LA and AT combination for 2 months · Healthy adults; age and sex not specified
400 IU120 days16
Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress
1999 · AT alone for 2 months, followed by LA and AT combination for 2 months · Healthy adults; age and sex not specified
400 IU120 days15
Oxidative stress response to aerobic exercise: comparison of antioxidant supplements
2006 · V treatment · Aerobically trained men and women
400 IU2 weeks15
Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men
400 mg1 day15
Antioxidant Supplementation Protects Elite Athlete Muscle Integrity During Submaximal Training
2022 · antioxidant supplementation (AS) · Elite-level endurance athletes
1,000 IU6 weeks15
Antioxidant supplementation enhances neutrophil oxidative burst in trained runners following prolonged exercise
2003 · antioxidant vitamin supplement · Healthy trained endurance runners; 6 men and 6 women, mean age 30.1 years
90 mg7 days12
The Effect of Omega-3 Fatty Acid Supplementation on Serum Adipocytokines, Lipid Profile and Biochemical Markers of Inflammation in Recreational Runners
2021 · ω-3 PUFA group · Healthy physically active male recreational marathon runners, with no stated disease; age range not reported
72 mg3 weeks12
Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation
1993 · combined antioxidant therapy · adult male subjects; age and health condition not specified
800 IU90 days12
Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin
2007 · zinc group · Patients with chronic hepatitis C receiving pegylated interferon alpha-2b and ribavirin therapy
300 mg48 weeks11
Protective effect of alpha-tocopherol and L-ascorbic acid against the ischemic-reperfusion injury in patients during open-heart surgery
1991 · Group 2 · Adults undergoing cardiopulmonary bypass for treatment of cardiac disease; age and sex not reported
2,000 IU1 day11
Effects of supplementation of antioxidant vitamins and lipid peroxidation in critically ill patients
2013 · G2 · Critically ill patients; age and sex not reported
400 mg8 days11
Effect of nutrition intervention on antioxidant capacity and lipid peroxide in patients with bone marrow transplantation
2002 · experimental group · Bone marrow transplantation recipients; age and sex not reported
600 mg15 days10
Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients
2005 · antioxidant supplementation phase · renal transplant recipients taking cyclosporin A; age and sex not reported
400 IU26 weeks10
Sex differences in the inhibition of gamma-tocopherol metabolism by a single dose of dietary sesame oil in healthy subjects
2008 · Sesame oil muffin treatment · Healthy adult women and men; ages not stated
100 mg1 day10
Phototoxic lysis of erythrocytes from humans is reduced after oral intake of ascorbic acid and d-alpha-tocopherol
1997 · vitamins group · Human volunteers; age and sex not specified; no stated condition
1,000 IU7 days10
Combined antioxidant treatment effects on blood oxidative stress after eccentric exercise
2005 · antioxidant supplement · Women aged 19–31 years who were not resistance-trained, undergoing eccentric elbow-flexor exercise
400 IU16 days9
Total radical-trapping antioxidant potential (TRAP) of plasma: effects of supplementation of young healthy volunteers with large doses of alpha-tocopherol and ascorbic acid
1993 · Group 4, alpha-tocopherol and ascorbic acid · Young healthy adults; age range and sex not reported
1 g4 weeks8
Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle
2004 · Treatment · Young healthy men
400 IU4 weeks7
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment
2003 · antioxidant supplementation · 11 antiphospholipid antibody-positive patients
900 IU6 weeks6
Effects of eicosapentaenoic acid supplementation in the treatment of chronic hepatitis C patients
2005 · EPA group · Patients with chronic hepatitis C receiving interferon alpha-2b and ribavirin; age and sex not reported
300 mg24 weeks5
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · fish oil (FO) · Healthy subjects; age and sex not specified
205 mg12 weeks—
Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial
2001 · Selenium with alpha-tocopherol and zinc · Critically ill trauma patients, mean age 42 years, with severe multiple injury
150 mg5 days—
Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study
2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population
30 mg2 years—
Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes
2002 · antioxidant-supplemented group · Sportsmen; age and health condition not specified
500 mg90 days—
Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial
2002 · vitamins C + E · nonsmokers
400 IU60 days—
Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function
2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified
200 mg8 weeks—
Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial
2003 · vitamins E and C · Adults with stable, inactive or mildly active Crohn's disease and oxidative stress
800 IU4 weeks—
Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers
2003 · group B · Healthy smokers; age range and sex not reported
400 IU4 weeks—
Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers
2003 · group C · Healthy smokers; age range and sex not reported
800 IU4 weeks—
Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers
2003 · Vitamins before breakfast · 11 people with type 2 diabetes
800 IU1 day—
Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers
2003 · Vitamins before supper · 11 people with type 2 diabetes
800 IU1 day—
Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation
2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation
30 mg3 weeks—
Antioxidant vitamins decrease exercise-induced QT dispersion after myocardial infarction
2003 · vitamin C and E · Patients with acute myocardial infarction; age and sex not specified
600 mg2 weeks—
Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers
2003 · group B · Healthy young chronic smokers; age and sex not specified
400 IU4 weeks—
Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers
2003 · group C · Healthy young chronic smokers; age and sex not specified
800 IU4 weeks—
Antioxidant diet supplementation influences blood iron status in endurance athletes
2004 · antioxidant supplemented · Amateur trained male endurance athletes
500 mg90 days—
Antioxidant supplementation and nasal inflammatory responses among young asthmatics exposed to high levels of ozone
2004 · vitamin supplement group · Children with asthma living in Mexico City
50 mg120 days—
Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers
2005 · antioxidant vitamin supplementation · smokers who smoked at least 10 cigarettes per day and had serum cotinine of at least 25 ng/mL; both men and women enrolled
400 IU456 days—
Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study
2005 · vitamin-treated group · Patients with systemic lupus erythematosus (SLE); age and sex not stated
800 IU12 weeks—
Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment
2005 · antioxidant treatment group · Men with unexplained infertility and at least 15% DNA-fragmented spermatozoa in the ejaculate
1 g60 days—
Response of blood cell antioxidant enzyme defences to antioxidant diet supplementation and to intense exercise
2006 · antioxidant supplemented · Amateur trained male athletes; age and health condition not specified
500 mg90 days—
Vitamin E isoform-specific inhibition of the exercise-induced heat shock protein 72 expression in humans
2006 · CEalpha · Young men
400 IU4 weeks—
Vitamin E isoform-specific inhibition of the exercise-induced heat shock protein 72 expression in humans
2006 · CEalphagamma · Young men
420 IU4 weeks—
A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins
2006 · micronutrient supplementation · Disease-free people in a rural Chinese population; age and sex not specified
200 IU2666 days—
Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults
2006 · overweight adults receiving antioxidant treatment · overweight adults aged 18–30 years
800 IU8 weeks—
Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults
2006 · normal-weight adults receiving antioxidant treatment · normal-weight adults aged 18–30 years
800 IU8 weeks—
Multivitamin-mineral supplementation prevents lipid peroxidation during "the Marathon des Sables"
2007 · Supplemented group · Athletes participating in the Marathon des Sables; age and sex not specified
24 mg4 weeks—
Antioxidant diet supplementation enhances aerobic performance in amateur sportsmen
2007 · antioxidant-supplemented group · Amateur male athletes; age and health condition not stated
500 mg90 days—
Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women
2009 · multivitamins without vitamin A and β-carotene (MV) · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum
30 mg——
Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women
2009 · multivitamins including vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum
30 mg——
Effect of citrus flavonoids and tocotrienols on serum cholesterol levels in hypercholesterolemic subjects
2007 · Supplement group, G1 · Men and women aged 19–65 years with hypercholesterolemia (cholesterol >230 mg/dL)
30 mg4 weeks—
Effect of citrus flavonoids and tocotrienols on serum cholesterol levels in hypercholesterolemic subjects
2007 · Supplement group, G2 · Men and women aged 19–65 years with hypercholesterolemia (cholesterol >230 mg/dL)
30 mg4 weeks—
Effect of citrus flavonoids and tocotrienols on serum cholesterol levels in hypercholesterolemic subjects
2007 · Supplement group, G3 · Men and women aged 19–65 years with hypercholesterolemia (cholesterol >230 mg/dL)
30 mg12 weeks—
Gender comparisons of exercise-induced oxidative stress: influence of antioxidant supplementation
2007 · antioxidant (A) · Men and women who ran for 30 minutes at 80% VO2 max; ages and health conditions not stated
400 IU2 weeks—
Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome
2008 · AT+GT combination · Adults recruited from the community with at least three features of metabolic syndrome
1.6 g6 weeks—
Inflammatory response to a high-fat, low-carbohydrate weight loss diet: effect of antioxidants
2008 · antioxidant supplement (AS) · Overweight adults with BMI >27 kg/m²; age and sex not specified
800 IU7 days—
Influence of an antioxidant vitamin-enriched drink on pre- and post-exercise lymphocyte antioxidant system
2008 · antioxidant supplementation · Male amateur trained runners aged 32–36 years
50 mg30 days—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 1 · Adults aged 60–75 years; elderly participants
200 mg16 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 2 · Adults aged 60–75 years; elderly participants
200 mg16 weeks—
[Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person]
2008 · Group 3 · Adults aged 60–75 years; elderly participants
200 mg16 weeks—
Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults
2009 · Normal-weight antioxidant-treated (N-AOX) · Apparently healthy men and women aged 18–30 years with BMI <25 kg/m²
800 IU8 weeks—
Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults
2009 · Overweight antioxidant-treated (O-AOX) · Apparently healthy men and women aged 18–30 years with BMI ≥25 kg/m²
800 IU8 weeks—
Cytokine response to vitamin E supplementation is dependent on pre-supplementation cytokine levels
2008 · vitamin E · Adults aged 66–100 living in long-term care facilities
200 IU1 year—
Serum vaspin concentrations are decreased after exercise-induced oxidative stress
2010 · antioxidant supplementation · healthy young men after a standardized 4-week physical training program
400 IU4 weeks—
Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation
2011 · n-3 PUFA plus antioxidant vitamins · Either-sex patients undergoing on-pump cardiac surgery
400 IU——
Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation
2011 · Antioxidant vitamins C and E without n-3 PUFA · Either-sex patients undergoing on-pump cardiac surgery
400 IU——
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures
2012 · E/C/ALA · Adults aged 50–85 with probable Alzheimer disease and MMSE scores of 16 or more
800 IU16 weeks—
New chitin complexes and their anti-aging activity from inside out
2012 · ORAL MEB · Healthy women aged 22–45 with signs of photoaging
3.2 mg12 weeks—
New chitin complexes and their anti-aging activity from inside out
2012 · ORAL CN-MEB · Healthy women aged 22–45 with signs of photoaging
3.2 mg12 weeks—
Prevention of neutrophil protein oxidation with vitamins C and E diet supplementation without affecting the adaptive response to exercise
2013 · antioxidant supplementation · Trained male amateur runners
50 mg30 days—
Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension
2014 · vitamin C + E · Men with essential hypertension; age range not reported
400 IU8 weeks—
Multinutrient-fortified juices improve vitamin D and vitamin E status in children: a randomized controlled trial
2014 · CaDEA · Children aged approximately 8 years
12 IU12 weeks—
Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents
2014 · antioxidant supplementation · Overweight or obese children and adolescents; mean age 12.7 ± 1.5 years
400 IU120 days—
Antioxidants may Attenuate Plasma Erythropoietin Decline after Hyperbaric Oxygen Diving
2015 · vitamin group · healthy male police task force divers exposed to repeated hyperbaric oxygen diving
600 IU3 days—
Vitamin C and E supplementation prevents some of the cellular adaptations to endurance-training in humans
2015 · antioxidant group · healthy young males
400 IU8 weeks—
Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress
2016 · vitamin E+selenium · men aged 55 years or older (50 or older for African Americans) who were current smokers without COPD
400 IU3 years—
Derepression of glomerular filtration, renal blood flow and antioxidant defence in patients with type 2 diabetes at high-risk of cardiorenal disease
2020 · vitamin E and selenium · Adults with type 2 diabetes and hypertension and/or microalbuminuria, eGFR >45 mL/min/1.73 m²; non-Caucasian or Caucasian
400 IU1 year—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants only · Adults aged 55–80 with early or more advanced age-related macular degeneration
400 IU5 years—
Lipid peroxidation and antioxidative vitamins under extreme endurance stress
1994 · Supplemented group · Trained long-distance runners; age and sex not reported
400 IU32 days—
Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise
1993 · antioxidant vitamin group · Young healthy males, mean age 25.0 years
592 mg6 weeks—
Antioxidants, Helicobacter pylori and stomach cancer in Venezuela
1996 · Treatment 2 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified
75 mg7 days—
Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network
1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized
15 mg26 weeks—
Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation
1997 · beta-carotene plus alpha-tocopherol · Male medical students; age not reported; no condition reported
400 IU10 weeks—
Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans
1997 · Menhaden oil with vitamin E · Healthy men; age not stated
900 IU6 weeks—
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease
1997 · mid-dose · Patients with established cardiovascular disease
400 IU12 weeks—
Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease
1997 · high dose · Patients with established cardiovascular disease
800 IU12 weeks—
Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters
1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common
15 mg2 years—
Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX
1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care
15 mg1 year—
Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects
1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years
30 mg26 weeks—
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
1998 · antioxidants without n-3 fatty acids · adult male smokers with hyperlipidaemia
75 mg6 weeks—
Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)
1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated
400 mg4 weeks63
Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk
2004 · antioxidant-supplemented group · Middle-aged men: myocardial infarction survivors younger than 50 and healthy controls
100 mg12 weeks53
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD
2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m²
300 mg2 years47
[Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children]
2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area
100 mg8 weeks41
Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status
1991 · antioxidant-supplemented men · Men with low antioxidant status
300 mg150 days39
Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome
2006 · test group · Patients with metabolic syndrome; age and sex not specified
7.5 mg90 days36
The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial
2019 · Multinutrient supplementation group · Women aged 19–35 with polycystic ovary syndrome (PCOS)
30 mg90 days30
Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study
2022 · TG1 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions
45 mg12 weeks30
Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study
2022 · TG2 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions
90 mg6 weeks30
Consumption of Hen Eggs Enriched with n-3 Polyunsaturated Fatty Acids, Selenium, Vitamin E and Lutein Incites Anti-Inflammatory Conditions in Young, Healthy Participants - A Randomized Study
2022 · 4Nutri group · Young, healthy participants; age range and sex not stated
3.29 mg3 weeks20
Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial
1994 · supplemented group · Healthy men aged 30–58 years who smoked 15–40 cigarettes per day
200 mg90 days20
Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes
2005 · group MV · Patients with type 2 diabetes; age range and sex not specified
100 IU90 days17
Effects of baked products enriched with n-3 fatty acids, folates, β-glucans, and tocopherol in patients with mild mixed hyperlipidemia
2012 · active diet · Adults with mild plasma lipid abnormalities (mild mixed hyperlipidemia)
120 mg30 days16
Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training
1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m
400 IU2 weeks—
Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation
2004 · antioxidant mixture · Healthy adult men and women who were active or passive smokers
794 mg60 days—
Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study
2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
30 mg2738 days—
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration
2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration
400 IU2433 days—
Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial
2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified
800 mg120 days—
Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise
2011 · LCPUFA plus antioxidant mixture · Judoists; age and sex not reported; no diagnosed condition stated
30 mg6 weeks—
New chitin complexes and their anti-aging activity from inside out
2012 · COMBINED MEB · Healthy women aged 22–45 with signs of photoaging
3.2 mg12 weeks—
New chitin complexes and their anti-aging activity from inside out
2012 · COMBINED CN-MEB · Healthy women aged 22–45 with signs of photoaging
3.2 mg12 weeks—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration
400 IU5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
400 IU5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation without β-carotene · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
400 IU5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
400 IU5 years—
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration
2025 · AREDS2 original AREDS formulation without β-carotene and with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation
400 IU5 years—
Response of hypercholesterolemic subjects to administration of tocotrienols
1995 · Palmvitee group · Hypercholesterolemic subjects; age and sex not specified
260 mg4 weeks—
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · antioxidants · male smokers with combined hyperlipidemia
75 mg6 weeks—
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
1997 · omega-3 FAs and antioxidants · male smokers with combined hyperlipidemia
75 mg6 weeks—
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
1998 · n-3 fatty acids with antioxidants · adult male smokers with hyperlipidaemia
75 mg6 weeks—
Does combined antioxidant vitamin supplementation blunt repeated bout effect?
2015 · supplement (S) group · moderately trained males
400 IU2 weeks—
[L-carnitine improves sperm acrosin activity in male infertility patients]
2018 · Control group · Male infertility patients with low sperm acrosin activity; age not reported
300 mg90 days60
Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults
2003 · spread C · healthy adults
1.3 mg11 weeks35
Effect of the omega-3 fatty acid plus vitamin E supplementation on subjective global assessment score, glucose metabolism, and lipid concentrations in chronic hemodialysis patients
2016 · vitamin E + omega-3 fatty acids placebo · Chronic hemodialysis patients; age and sex not specified
400 IU12 weeks30
Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans
2002 · 25 mg/day TRF25 group · Hypercholesterolemic human subjects on the AHA Step-1 diet; age and sex not specified
25 mg5 weeks18
Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans
2002 · 50 mg/day TRF25 group · Hypercholesterolemic human subjects on the AHA Step-1 diet; age and sex not specified
50 mg5 weeks18
Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans
2002 · 200 mg/day TRF25 group · Hypercholesterolemic human subjects on the AHA Step-1 diet; age and sex not specified
200 mg5 weeks18
Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects
2006 · Healthy subjects, 100 mg/day · 12 healthy subjects
100 mg3 weeks12
Alpha-tocopherol distribution in lipoproteins and anti-inflammatory effects differ between CHD-patients and healthy subjects
2006 · Healthy subjects, 200 mg/day · 12 healthy subjects
200 mg3 weeks12
Sex differences in the inhibition of gamma-tocopherol metabolism by a single dose of dietary sesame oil in healthy subjects
2008 · Corn oil muffin treatment · Healthy adult women and men; ages not stated
100 mg1 day10
Supplementation with antioxidants prior to bone marrow transplantation
1997 · Healthy control group · Healthy controls
825 mg3 weeks10
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione
2002 · vitamin E · Patients who survived a recent myocardial infarction (<3 months)
300 mg——
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione
2002 · n-3 PUFAs plus vitamin E · Patients who survived a recent myocardial infarction (<3 months)
300 mg——
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration
2007 · antioxidants · Adults aged 55–80 with age-related macular degeneration
400 IU2433 days—
Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk
2009 · β-carotene plus vitamin E group · Men aged 50–69 years in southwestern Finland who smoked at least five cigarettes per day
50 mg2228 days—